New Instrumental Variable Methods for Causal Inference. by Lehmann, Douglas A.
New Instrumental Variable Methods for Causal
Inference
by
Douglas A. Lehmann
A dissertation submitted in partial fulfillment
of the requirements for the degree of
Doctor of Philosophy
(Biostatistics)
in The University of Michigan
2016
Doctoral Committee:
Professor Yi Li, Co-chair
Research Associate Professor Yun Li, Co-chair
Professor Rajiv Saran
Professor Douglas Schaubel
“We shall not cease from exploration,
and the end of all our exploring
will be to arrive where we started
and know the place for the first time.”
- T.S. Eliot
c© Douglas A. Lehmann 2016
All Rights Reserved
ACKNOWLEDGEMENTS
I would like to thank my dissertation committee, Professor Yi Li, Research As-
sistant Professor Yun Li, and Professor Douglas Schaubel, of the Department of
Biostatistics; and Professor Rajiv Saran, of the Department of Internal Medicine. I
am very grateful for their help, which has guided my research.
Yi has funded me and remained supportive of my work throughout my time as a
doctoral student. He has been an excellent mentor and sets a good example for his
students. His help and advice during my job hunt has altered the trajectory of my
life for the better.
Yun introduced me to instrumental variables research, and deserves all the credit
for getting me started in the right direction when I had no idea what I would do.
She has spent much time working very closely with me, and I am grateful for the
patience she has shown me over the years. Her enthusiasm about my work has been
uplifting, and I have always left meetings feeling better than I did going in.
Doug has had honest and straightforward advice whenever I needed it. He has
always left me knowing exactly what I had to do next and how to do it. He also
taught me most of what I know about working with survival data.
Rajiv has been my clinical mentor. Our collaborative meetings have shaped the
applications presented in this dissertation and have taught me much about the com-
plicated issues related to kidney dialysis.
I would also like to thank two close friends and fellow students, John Rice and
ii
Alex Smith, who have had a big impact on my time at Michigan. Having begun the
PhD at the same time, John and I faced many of the same challenges together. I am
thankful for the times he has worked through my R code when I was stuck, and his
unparalleled knowledge of English grammar has helped immensely while writing this
dissertation. Alex has made the many late nights in the office enjoyable. He is the
first person I go to for help with editing. He also deserves credit for introducing me
to healthy eating, backpacking, and the Pomodoro technique for time management,
all of which have improved my life greatly.
This research was funded in part with federal funds from the National Institute
of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, De-
partment of Health and Human Services, under Contract No. HHSN276201400001C.
Support was also provide by the National Institutes of Health grant 5R01DK070869-
09.
The data reported in this dissertation have been supplied by the United States
Renal Data System (USRDS), which is funded by the National Institute of Diabetes
and Digestive and Kidney Diseases (NIDDK). The interpretation and reporting of
these data are the responsibility of the authors and in no way should be seen as an
official policy or interpretation of the U.S. government.
iii
TABLE OF CONTENTS
ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ii
LIST OF FIGURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vi
LIST OF TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . vii
LIST OF APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . viii
CHAPTER
I. An Introduction to Instrumental Variables . . . . . . . . . . . . . . . . . . . . 1
II. A Weighted Estimator of the Local Average Treatment Effect with Ob-
served Confounders . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
2.1 Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
2.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
2.2.1 Notation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
2.2.2 Proposed Estimator . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2.3 Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
2.3.1 Setup . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
2.3.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
2.4 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2.5 Future Work . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2.6 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
III. Strengthening Instrumental Variables Through Weighting . . . . . . . . . . 38
3.1 Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
3.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
3.3 Inference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
3.3.1 Notation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
3.3.2 Assumptions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
3.3.3 Estimation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
3.4 Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
3.4.1 Setup . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
3.4.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3.5 Data Example . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51
3.6 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54
IV. Properties of Strengthened Instrumental Variables . . . . . . . . . . . . . . 56
4.1 Motivation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 56
iv
4.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
4.2.1 IV-Matching . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
4.2.2 Weighted IV-Matching . . . . . . . . . . . . . . . . . . . . . . . . . 60
4.2.3 Near-far Matching . . . . . . . . . . . . . . . . . . . . . . . . . . . 61
4.3 Inference . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
4.3.1 Estimation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
4.3.2 Sensitivity Analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
4.4 Simulations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
4.4.1 Setup . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 65
4.4.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 66
4.5 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
V. Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 74
APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 76
BIBLIOGRAPHY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
v
LIST OF FIGURES
Figure
1.1 Causal diagram depicting the relationship between variables and the assumptions
of an instrumental variable analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
2.1 IV-matching weight by IV propensity score . . . . . . . . . . . . . . . . . . . . . . 15
2.2 k:1 IV-matching weight by IV propensity score . . . . . . . . . . . . . . . . . . . . 18
2.3 Distribution of longer dialysis sessions by hospital service area . . . . . . . . . . . . 26
3.1 Balance of covariates used in Chapter III data example, displayed before and after
matching . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 53
4.1 Simulation results displaying the separation of the instrument by magnitude of
instrument-outcome confounding . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
4.2 Simulation results for assessing estimation, 95% confidence interval widths, and
95% coverage probabilities for each method . . . . . . . . . . . . . . . . . . . . . . 68
4.3 Simulation results investigating the ratio of correlation between instrument and
unmeasured instrument-outcome confounder to correlation between instrument and
treatment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 69
4.4 Simulation results for assessing sensitivity to unmeasured instrument-outcome con-
founding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71
vi
LIST OF TABLES
Table
2.1 Population subgroups defined by an individuals response to encouragement in an
IV analysis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
2.2 Bias, mean squared error, and 95% coverage probabilities from simulations to study
the performance of the IV-MW estimator . . . . . . . . . . . . . . . . . . . . . . . 21
2.3 A comparison of empirical standard deviations and estimated standard deviations
using the sandwich variance procedure of Section 2.2.2 . . . . . . . . . . . . . . . . 22
2.4 Simulation results for studying the performance of the double robust IV-MWDR
estimator . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
2.5 Distribution of covariates used in Chapter II data example across treatment and
instrument groups . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.6 Estimated effects of longer dialysis sessions on first year mortality . . . . . . . . . . 27
2.7 Simulation results to study the performance of IV-MW estimator for estimating
difference in mean survival . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34
2.8 Estimated difference in restricted mean survival between patients with longer or
shorter dialysis session lengths . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
3.1 Simulation results for assessing instrument strength achieved by the IVM, WIVM,
and NFM methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
3.2 Simulation results for assessing the balance of covariates achieved by the IVM,
WIVM, and NFM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
3.3 Simulation results for assessing the bias, mean squared error, and 95% coverage
probabilities of the IVM, WIVM, and NFM methods . . . . . . . . . . . . . . . . . 50
3.4 Estimated effects of peritoneal dialysis on early mortality . . . . . . . . . . . . . . 54
vii
LIST OF APPENDICES
Appendix
A. Asymptotic equivalence of IV-MW and IV-PSM estimators . . . . . . . . . . . . . . . 77
B. Full list of covariates used in data example of Chapter III . . . . . . . . . . . . . . . . 81
viii
CHAPTER I
An Introduction to Instrumental Variables
The randomized controlled trial (RCT) is considered the “gold standard” for eval-
uating the effectiveness of a treatment or intervention. Randomizing subjects to a
treatment helps to ensure that treatment groups are comparable on both measured
and unmeasured covariates. When treatment groups are comparable, effects can be
obtained through direct comparisons using standard statistical methods. While this
is a major benefit of RCTs, they are not without limitations. They can be costly,
and in some cases it is impossible or even unethical to randomize the treatment. Ob-
servational data are an increasingly common alternative to RCTs, but come at the
cost of removing control over treatment assignment from the hands of the researcher.
This gives rise to the possibility of systematic differences between treatment groups.
While it may be possible to measure and control for certain covariates, there re-
mains a possibility that treatment groups differ in unmeasured ways that confound
the relationship of interest. This is a primary concern in any observational study,
and methods that ignore this unmeasured confounding give biased and potentially
misleading results.
Instrumental variable (IV) methods are widely used to deal with this issue and
are becoming increasingly popular in health and medical research. IV models are
1
2able to obtain consistent effect estimates in the presence of unmeasured confound-
ing between the treatment and outcome, but rely on assumptions that are hard to
prove and often criticized (Wooldridge, 2001). A key component of an IV analy-
sis is the instrumental variable, or the instrument. The instrument is a variable
that influences or encourages individuals toward a particular treatment without di-
rectly affecting the outcome. In this sense, the instrument mimics randomization
by randomly “assigning” individuals to different likelihoods of receiving the treat-
ment. An instrument must satisfy three basic assumptions (Angrist et al., 1996;
Baiocchi et al., 2014). Presented graphically in Figure 1.1, the instrument 1) must
be correlated with the treatment, 2) must be randomly assigned, or independent of
unmeasured confounders, and 3) cannot directly affect the outcome.
Instrument Outcomex
3
Unmeasured Confounders
Treatment
x2
1
Figure 1.1: Causal diagram depicting the relationship between variables in an instrumental variables
analysis, as well as the assumptions imposed on the instrument.
The assumption that the instrument is randomly assigned implies that there are
no unmeasured confounders between the instrument and the outcome. Unfortu-
nately, this cannot be verified to hold and the assumption often faces criticism. This
assumption is easy to justify when an instrument is based on a truly random process,
for example using treatment assignment as an instrument for treatment received in
a randomized trial with noncompliance. Without actual randomization, however,
finding an instrument that meets this criteria can be a difficult task. In observa-
tional studies it is more common to find an instrument that, although not subject
3to randomization, arguably meets this assumption after controlling for a set of mea-
sured instrument-outcome confounders (Garabedian et al., 2014). In other words,
the instrument is argued to be conditionally distributed “as good as random.” For
example, regional treatment preferences may serve as a reasonable instrument after
controlling for patient characteristics such as race, age, education, income, insur-
ance status and comorbidities, geographic characteristics such as rural/urban status
and socioeconomic indicators, and provider characteristics such as procedure vol-
ume, supply, and profit or teaching status. Garabedian et al. (2014) discuss the
most common instruments and potential instrument-outcome confounders associ-
ated with each, and emphasize that failing to control for these confounders violates
the assumption that the instrument is randomly assigned and can bias estimation.
In Chapter II we propose a weighted IV estimator that controls for measured
instrument-outcome confounders using the IV propensity score. The IV propensity
score represents the probability that an individual is encouraged, based on their
instrument value, toward the treatment. This is different from the more common
treatment propensity score, which is the probability that an individual actually re-
ceives the treatment. Similar to the treatment propensity score (Rosenbaum and
Rubin, 1983; Lunceford and Davidian, 2004), the IV propensity score balances the
distribution of observed covariates across instrument groups while reducing the di-
mension of the adjustment problem, a major benefit as the number of covariates
increases. Unlike the treatment propensity score, which is only useful for address-
ing measured treatment-outcome confounding, methods based on the IV propensity
score can provide consistent effect estimates in the presence of both measured and
unmeasured confounders between the treatment and the outcome.
The proposed estimator uses weights that are designed to approximate the prob-
4ability of being selected into a one-to-one match on the IV propensity score (Fro¨lich,
2007), though we present an extension for approximating k:1 matching designs as
well. We therefore refer to the proposed estimator as the IV-matching weight estima-
tor. We show that the IV-matching weight estimator has several benefits over one-to-
one IV propensity score matching. These include increased efficiency in estimation,
straightforward variance estimation, and speed of computation. The IV-matching
weight estimator is further shown to be more efficient than alternative weighting
estimators (Tan, 2006), possibly a result of using stable weights that are bounded
between 0 and 1.
While we develop this estimator for use with binary outcomes, we present prelimi-
nary research on applying the method to time-to-event or survival data. Specifically,
we modify the procedure to estimate the difference in mean survival between groups,
although other estimands relevant to survival studies may be considered as well.
Given the importance of survival data in health and medical research, this work has
potential for a broad applications.
Chapter III is concerned with the strength of the correlation between the instru-
ment and the treatment, specifically how this strength can be increased. Instru-
ments with little influence over treatment assignment are termed weak instruments,
and there are a number of problems associated with using them. They suffer from
greater finite-sample bias and greater variability in estimation (Bound et al., 1995;
Wooldridge, 2001). Additionally, results obtained using weak instruments are sensi-
tive to violations of the assumption that the instrument is randomly assigned (Bound
et al., 1995; Small and Rosenbaum, 2008; Baiocchi et al., 2010). Given the critical na-
ture of this assumption, the robustness provided by stronger instruments is a major
benefit and has motivated recent methods for strengthening the instrument.
5We develop a novel method for strengthening the instrument within the IV-
matching framework of Baiocchi et al. (2010, 2012). The proposed method involves
weighting pairs based on a within-pair measure of instrument strength in a way that
increases the strength of the instrument across all pairs. Compared with existing
methods for strengthening the instrument (Baiocchi et al., 2010, 2012), the proposed
weighting procedure is able to strengthen the instrument without compromising the
quality of matches formed. Match quality is a priority in any matching design, since
poor match quality can lead to biased and misleading estimated effects. The im-
proved match quality is therefore an important benefit of weighting over existing
alternatives.
Finally, in Chapter IV we investigate instrumental variable estimation using strength-
ened instruments to better understand their properties. Theory suggests that stronger
instruments provide for decreased finite-sample bias, increased efficiency in esti-
mation, and results that are more robust to unmeasured instrument-outcome con-
founders (Bound et al., 1995; Wooldridge, 2001; Small and Rosenbaum, 2008). These
benefits have motivated methods for strengthening weak instruments, including those
of Baiocchi et al. (2010, 2012) and that proposed in Chapter III. It has yet to be
shown, however, that strengthened instruments provide the same benefits as instru-
ments that are naturally stronger. We use the term “strengthened” to refer to any
instrument whose strength has been increased by the researcher, and the term “nat-
urally stronger” to refer to instrument that is more correlated with the treatment
without the research increasing this correlation.
Our findings suggest that while strengthened instruments provide for more ef-
ficient estimation, they are unable to decrease finite-sample bias or improve the
robustness to unmeasured instrument-outcome confounders as previously suggested.
6We find that methods for strengthening the instrument inadvertently strengthen the
relationship between the instrument and any unmeasured instrument-outcome con-
founders in the process. This important finding has thus far been overlooked in the
literature, and has likely led to the belief that strengthened instruments provide esti-
mates that are more robust to unmeasured instrument-outcome confounders. These
findings give guidance for future research related to methods for strengthening the
instrument.
CHAPTER II
A Weighted Estimator of the Local Average Treatment
Effect with Observed Confounders
2.1 Motivation
Instrumental variable (IV) methods are widely used to deal with the selection bias
or unmeasured confounding that is often present in observational studies. While IV
models can obtain consistent estimates in the presence of this unmeasured confound-
ing, they rely on assumptions that are difficult to verify and often criticized. A key
component of an IV analysis is the instrument, a variable that is considered to en-
courage individuals toward the treatment or control. The instrument is assumed to
be correlated with the treatment, have no direct effect on the outcome outside of
its effect on the treatment, and be randomly assigned (Angrist et al., 1996; Baiocchi
et al., 2014).
The assumption that the instrument is randomly assigned implies that there are
no unmeasured instrument-outcome confounders. This assumption is easy to make
when an instrument is based on actual randomization, for example using the treat-
ment that a subject is randomly assigned to as an instrument for the treatment a
subject ultimately receives in a randomized trial that suffers from noncompliance.
Such instruments are rarely available in observational studies, however, and it is more
common to find an instrument that meets this requirement only after controlling for
7
8a set of measured instrument-outcome confounders. In other words, the instrument
is conditionally distributed “as good as random.” For example, regional treatment
preference may serve as a reasonable instrument after controlling for patient char-
acteristics such as race, age, education, income, insurance status and comorbidities,
geographic characteristics such as rural/urban status, socioeconomic indicators, and
provider characteristics such as procedure volume, supply, and profit or teaching
status. Garabedian et al. (2014) discuss the most commonly used instruments and
potential instrument-outcome confounders associated with each, and emphasize that
failing to adjust for these can bias estimation.
Instrument-outcome confounders can be adjusted for in several ways. They can be
included as covariates in two stage regression models. While two stage least squares
is the most common among these, it may be inappropriate for binary outcomes
(Bhattacharya et al., 2006). Two stage residual inclusion was proposed in Terza
et al. (2008) for use with binary outcomes. Matching on confounders is a common
nonparametric alternative to these regression methods, but becomes difficult when
there are many confounders or confounders with many discrete levels. Though less
common in practice, methods have proposed using the IV propensity score rather
than the full set of confounders. These include the inverse probability weighting
estimator of Tan (2006), the matching estimator of Fro¨lich (2007), and the weighting
and subclassification methods of Cheng and Lin (2013).
The IV propensity score is the probability that an individual is encouraged toward
the treatment, as indicated by their instrument value. This is different from the
more common treatment propensity score, which represents the probability that an
individual actually receives the treatment. Like the treatment propensity score, the
IV propensity score balances the distribution of confounders across groups while
9reducing the dimension of the adjustment problem (Rosenbaum and Rubin, 1983;
Lunceford and Davidian, 2004). Unlike the treatment propensity score, which is only
useful for addressing measured treatment-outcome confounding, methods based on
the IV propensity score can provide consistent effect estimates in the presence of
both measured and unmeasured treatment-outcome confounding.
In this chapter we propose an IV estimator based on the IV propensity score.
It is a weighted estimator that uses weights designed to reflect the probability of
being selected into a one-to-one IV propensity score match. One-to-one IV propen-
sity score matching involves pairing encouraged subjects to unencouraged subjects
with similar scores, usually within a specified range. Often a match cannot be found
within this range. Pairing the encouraged subject to an unencouraged subject with
a score outside of this range can bias estimation, whereas dropping the encouraged
subject reduces sample size which leads to a decrease in efficiency. Furthermore,
matching becomes a computationally difficult task as sample size increases. The
proposed estimator avoids these pitfalls associated with matching. An additional
benefit of weighting estimators is that they allow for straightforward variance esti-
mation, whereas the correlation structures introduced by matching algorithms are
difficult to account for when estimating the variance of matching estimators (Austin,
2008, 2009b, 2011a).
We further present two extensions of the proposed estimator that could prove
useful in practice. The first is a modification to the weight function to approximate
k:1 matching designs. The second is an alternative formulation of the estimator
that provides protection against misspecification of the IV propensity score model.
Though this requires the additional specification of an outcome model, this double
robust estimator will give consistent estimates if at least one of the IV propensity
10
score or outcome models is correctly specified.
The remainder of this chapter is organized as follows. In Section 2.2 we define
notation, discuss the IV propensity score, and introduce our proposed estimator.
Finite-sample performance is reported through simulations in Section 2.3, and use
of the method is illustrated with a real data example in Section 2.4. Future work on
applying the method to survival data is presented in Section 2.5, and we conclude
with a discussion in Section 2.6.
2.2 Methods
2.2.1 Notation
We define notation using the potential outcomes framework (Rubin, 1974; Ney-
man, 1923; Angrist et al., 1996). For each of i = 1, ..., n subjects, let Zi = 1 if
subject i is encouraged toward the treatment and Zi = 0 if encouraged toward the
control. Let Di(Zi) indicate treatment received for subject i given their encourage-
ment status, and let Yi(Zi, Di(Zi)) indicate the response for subject i given their
encouragement status and treatment value. Di(Zi) and Yi(Zi, Di(Zi)) are referred
to as potential outcomes. When subject i is encouraged toward the treatment, we
observe treatment Di(1) and response Yi(1, Di(1)) from subject i, otherwise we ob-
serve treatment Di(0) and response Yi(0, Di(0)). Our interest is in estimating the
parameter
(2.1) λ =
E(Yi(1, Di(1))− Yi(0, Di(0)))
E(Di(1)−Di(0)) .
This is the ratio of the instrument’s effect on the response to its effect on the treat-
ment, and is often referred to as the local average treatment effect (LATE) (Imbens
and Angrist, 1994; Angrist et al., 1996). Rather than an average treatment effect
over the entire population, the LATE is interpreted as an average effect over a sub-
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group of the population known as compliers. Depicted in Table 2.1, compliers are
individuals that take the treatment they are encouraged toward, and are one of four
population subgroups defined by their response to encouragement.
Table 2.1: Population subgroups defined by the effect of encouragement on treatment. D(1) denotes
the treatment a subject will receive if they are encouraged toward treatment, while D(0)
denotes the treatment they will receive if they are encouraged toward the control.
D(1)
1 0
D(0)
1 Always-takers Defiers
0 Compliers Never-takers
The difficulty in estimating λ comes from the fact that we never observe individ-
uals under both states of encouragement, and therefore never observe both of their
potential outcomes. The data provides, for example, E(Yi(1, Di(1))|Zi = 1), or the
average response under encouragement among the encouraged subjects. This differs
from E(Yi(1, Di(1))), which is the average response over the entire population if the
entire population were encouraged. To recover the expectations in equation (2.1),
and to aid in the interpretation of λ, we make the following five assumptions (Angrist
et al., 1996):
A1. Stable Unit Treatment Value Assumption (SUTVA). Often known as no in-
terference, SUTVA requires that the outcomes for one subject be unaffected by the
encouragement status or treatment assignment of other subjects. This assumption
will be violated if spillover effects exist between patients or groups. SUTVA allows
us to consider a subjects potential outcomes as a function of their treatment and
encouragement, rather than a function of the treatment and encouragement assign-
ments of the entire population.
A2 - Random assignment of the instrument. The instrument is assumed to be ran-
domly assigned, which implies that there are no unmeasured confounders between
12
the instrument and the outcome. This assumption is often made conditional on
measured instrument-outcome confounders. It cannot be verified to hold, and weak
instruments are especially sensitive to violations of this assumption (Baiocchi et al.,
2014; Bound et al., 1995; Small and Rosenbaum, 2008; Staiger and Stock, 1994).
A3 - Exclusion restriction. The instrument is assumed to affect the outcome
only through its effect on the treatment. This implies that Yi(1, Di(1) = d) =
Yi(0, Di(0) = d) for all i, d. Since both potential outcomes are never observed for
any individual, this assumption cannot be verified to hold.
A4 - Nonzero association between instrument and treatment. The instrument is as-
sumed to be correlated with the treatment. This implies that E(Di(1)−Di(0)) 6= 0.
A5 - Monotonicity. Monotonicity is the assumption that no individual always
does the opposite of what they are encouraged to do. This implies that there are no
defiers (Table 2.1) and that Di(1) ≥ Di(0) for all i.
The SUTVA and random assignment assumptions allow for unbiased estimation
of the instrument’s effect on the outcome and the treatment, or the numerator and
denominator in (2.1). The remaining assumptions give λ a meaningful interpreta-
tion. By exclusion restriction, always- and never-takers (Table 2.1) do not contribute
to estimation since their treatment values, and therefore their response values, do
not vary with encouragement. Monotonicity ensures that the subgroup of defiers is
empty, while a nonzero association between the instrument and the treatment en-
sures that the subgroup of compliers is not empty. With the addition of assumptions
these three assumptions, λ can therefore be interpreted as an average treatment ef-
fect among the compliers, who are often referred to as “marginal patients.” Unlike
the average treatment effect, which is applicable to the entire population, λ only
applies to subjects that can be encouraged to switched treatment states. Further
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discussion of these assumptions can be found in Imbens and Angrist (1994), Angrist
et al. (1996) or Baiocchi et al. (2014), among many others.
2.2.2 Proposed Estimator
In this section we present our proposed estimator. It is a weighted IV estimator
of the local average treatment effect that adjusts for measured instrument-outcome
confounders using weights that are based on the IV propensity score. Defined as
(2.2) e(x) = P (Z = 1|X = x),
the IV propensity score represents the probability of receiving encouragement toward
the treatment. This is different from the more common treatment propensity score,
which represents the probability of actually receiving the treatment. From the theo-
rems of Rosenbaum and Rubin (1983), we can say that the distribution of covariates
X is balanced across instrument groups conditional on e(x), and if the instrument
is independent of unmeasured confounders conditional on X, then it is independent
of unmeasured confounders conditional on e(x) as well. Taken together, these two
statements imply that conditioning on e(x) is sufficient for adjusting for X.
Define the observed treatment and response values for subject i as Di = ZiDi(1)+
(1 − Zi)Di(0) and Yi = ZiYi(1, Di(1)) + (1 − Zi)Yi(0, Di(0)), respectively. Our pro-
posed estimator, which we refer to as the IV-matching weight (IV-MW) estimator,
is given as
(2.3) λIV-MW =
∑
iWiZiYi/
∑
iWiZi −
∑
iWi(1− Zi)Yi/
∑
iWi(1− Zi)∑
iWiZiDi/
∑
iWiZi −
∑
iWi(1− Zi)Di/
∑
iWi(1− Zi)
,
where weights Wi are defined as
(2.4) Wi =
min(ei(xi), 1− ei(xi))
Ziei(xi) + (1− Zi)(1− ei(xi)) .
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This weight is similar to the matching weight of Li and Greene (2013), but defined
using the IV propensity score rather than the treatment propensity score. The IV-
MW estimator is therefore useful for dealing with both measured and unmeasured
treatment-outcome confounding, whereas the estimator of Li and Greene (2013) is
useful only in the presence of measured treatment-outcome confounding but will not
provide consistent estimates if unmeasured treatment-outcome confounders exist.
Weights Wi are referred to as matching weights because they approximate the
probability of being selected into a one-to-one match on the IV propensity score.
The asymptotic equivalence of the IV-MW estimator with one-to-one matching on
the IV propensity score is shown in Appendix A, but we illustrate the idea here with a
simple example. Consider a region around IV propensity score e = 0.1 with m = 100
individuals. From (2.2), there is an expected me = 10 encouraged and m(1−e) = 90
unencouraged individuals in this region. All encouraged individuals are therefore
expected to find a match, and W = min(0.1, 0.9)/(1 × 0.1 + 0 × 0.9) = 1 for these
individuals. However, only 10 of the 90 unencouraged individuals are expected to
be matched, and W = min(0.1, 0.9)/(0× 0.1 + 1× 0.9) = 1/9 for these individuals.
Figure 2.1 displays the weight assigned to encouraged and unencouraged individuals
across the range of IV propensity scores.
Alternatives to the IV-MW estimator proposed in (2.1) include one-to-one IV
propensity score matching (Fro¨lich, 2007) and inverse probability weighting using
the IV propensity score (Tan, 2006). These two methods are, to the best of our
knowledge, the only published alternatives that make use of the IV propensity score
to control for measured instrument-outcome confounders. A benefit of the proposed
IV-MW estimator over one-to-one IV propensity score matching is that all subjects
contribute a fraction of themselves to estimation, avoiding the situation where in-
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Figure 2.1: Matching weights for encouraged and unencouraged subjects by IV propensity score.
dividuals are removed after not finding a suitable match. This avoids a decrease in
sample size and efficiency. A benefit of the proposed estimator over inverse probabil-
ity weighting using the IV propensity score is that the weights are bounded between
0 and 1, whereas inverse probability weights can “blow up” near probabilities 0 or
1, causing an increase in the variance of the estimate (Li et al., 2014). We therefore
expect the proposed IV-MW estimator to be more efficient than both one-to-one IV
propensity score matching and inverse probability weighting using the IV propensity
score.
An additional benefit of weighting estimators over matching based estimators is
that they allow for straightforward variance estimation. Matching algorithms intro-
duce complicated correlation structures that are difficult to account for when esti-
mating the variance of matching estimators. Often, the matched nature of the data
is ignored entirely (Austin, 2008, 2009b, 2011a). Following Lunceford and Davidian
(2004) and Li and Greene (2013), a sandwich type variance estimator is obtained
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using estimating equations
(2.5) 0 =
n∑
i=1
φi(θ) =
n∑
i=1

WiZi(Yi − µy1)
Wi(1− Zi)(Yi − µy0)
WiZi(Di − µd1)
Wi(1− Zi)(Di − µd0)
Sη(η)

,
where θ = (µy1, µy0, µd1, µd0,η
′), with µy1 = E(WiZiYi)/E(WiZi), µy0 = E(Wi(1 −
Zi)Yi)/E(Wi(1−Zi)) and similar for µd1 and µd0. Sη(η) represent estimating equa-
tions for coefficients η from the model used to estimate the IV propensity score, often
a logistic regression. An estimate of var(θˆ) is obtained as n−1Aˆ−1n Bˆn(Aˆ
T
n )
−1, where
Aˆn =
∑n
i=1 ∂φi(θ)/∂θ|θ=θˆ and Bˆn =
∑n
i=1 φi(θ)φ
T
i (θ)|θ=θˆ. Applying the multivariate
delta method with g(θ) = (µy1 − µy0)/(µd1 − µd0), an estimate of var(λˆ) is obtained
as ∇g(θ)T ˆvar(θˆ)∇g(θ). This procedure allows for simultaneous estimation of the IV
propensity score and λ, and is used for variance estimation for all estimators com-
pared in Sections 2.3 and 2.4. For the IV propensity score matching procedure, this
sandwich variance estimate ignores the matched nature of the sample. This typically
leads to an overestimated variance (Austin, 2009b, 2011a), though in simulations
reported in Section 2.3 the estimated and empirical standard deviations are found
to be approximately equal.
Note that Wi is not differentiable everywhere with respect to η due to the mini-
mum function in the numerator. To apply this variance estimation procedure, rewrite
the weight function as
(2.6) Wi =
ei(xi)I[ei(xi) ≤ 0.5] + (1− ei(xi))I[ei(xi) > 0.5]
Ziei(xi) + (1− Zi)(1− ei(xi)) .
These indicator functions can then be replaced with cumulative distribution functions
to create a smooth, differentiable function for Wi (Horowitz, 1992).
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In the following two sections we extend the IV-MW estimator in ways that could
prove useful in practice. We first adjust the weight function in (2.4) to approximate
a k:1 matching algorithm. We then modify the estimator in (2.3) for a double robust
IV-MW estimator that protects against misspecification of the IV propensity score
model. This requires the additional specification of an outcome model but will give
consistent estimates if at least one of the IV propensity score or outcome models is
correctly specified.
k:1 IV-matching Weights
The weights proposed in (2.4) are designed to approximate a one-to-one match
on the IV propensity score. While one-to-one matching is the most common in
practice (Austin, 2008), if the pool of unencouraged subjects is large enough we
might consider matching multiple unencouraged subjects to each encouraged subject.
Increasing the number of unencouraged subjects has the benefit of increasing the
sample size, thereby decreasing the variability in estimation. More on k:1 matching
using propensity scores, including guidance for the selection of k, can be found in
Austin (2010). For approximating k:1 matching designs, we redefine the weights as
(2.7) Wi =
min(kei(xi), 1− ei(xi))
Zikei(xi) + (1− Zi)(1− ei(xi)) .
As the number of unencouraged subjects to be matched increases, the probability
that they will be selected into a match for any given IV propensity score increases,
while decreasing the probability that encouraged subjects will be able to find k
individuals to match with. Figure 2.2 displays the weight assigned to encouraged
and unencouraged subjects across the range of IV propensity scores for one-, two-,
three-, and four-to-one IV propensity score matching.
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Figure 2.2: Weights for encouraged and unencouraged subjects across IV propensity scores for 1:1,
2:1, 3:1 and 4:1 matching designs. Weights for 1:1 matching are the same as Figure 2.1
Double Robust IV-MW Estimator
The IV-MW estimator in (2.3) requires correct specification of the IV propensity
score model for consistent estimation. In this section, we modify the IV-MW esti-
mator to protect against misspecification of the IV propensity score model. While
this requires the additional specification of an outcome model, the double robust
(IV-MWDR) estimator will provide consistent estimates if at least one of the IV
propensity score or outcome models is correctly specified, but does not require cor-
rect specification of both.
Let m0(Xi) = E {Yi|Xi, Zi = 0} denote the outcome model for the unencouraged
group and similarly let m1(Xi) the outcome model for the encouraged group. Follow-
ing from Lunceford and Davidian (2004) and Li and Greene (2013), a double robust
version of the IV-MW estimator is given as
(2.8) λIV-MWDR =
A+B − C∑
iWiZiDi/
∑
iWiZi −
∑
iWi(1− Zi)Di/
∑
iWi(1− Zi)
,
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where
A =
∑
i
Wi{m1(Xi)−m0(Xi)}/
∑
i
Wi,
B =
∑
i
WiZi{Yi −m1(Xi)}/
∑
i
WiZi,
C =
∑
i
Wi(1− Zi){Yi −m0(Xi)}/
∑
i
Wi(1− Zi).
Variance is estimated using the procedure of Section 2.2.2, with estimating equations
(2.9) 0 =
n∑
i=1
φi(θ) =
n∑
i=1

Wi{m1(Xi)−m0(Xi)− µA}
WiZi{Yi −m1(Xi)− µB}
Wi(1− Zi){Yi −m0(Xi)− µC}
WiZi(Di − µd1)
Wi(1− Zi)(Di − µd0)
S1(α1)
S0(α0)
Sη(η)

,
where θ = (µA, µB, µC , µd1, µd0,α
′
1,α
′
0,η
′). µA, µB, µC , µd1, and µd0 correspond
to the limits of A, B, C, and the averages in the denominator of (2.8). S1(α1) and
S0(α0) represent the estimating equations for the parameters in m1(Xi) and m0(Xi),
and Sη(η) the estimating equations for the parameters in the IV propensity score
model.
2.3 Simulation
2.3.1 Setup
In this section we report the results of simulation studies for investigating the
finite-sample performance of the proposed IV-MW estimator. We compare it with
two alternatives that make use of the IV propensity score: the inverse probability
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weighting (IV-IPW) estimator of Tan (2006) and one-to-one IV propensity score
matching (IV-PSM) (Fro¨lich, 2007). The IV-IPW estimator has the same form as
the IV-MW estimator in (2.1), but with the numerator of (2.4) replaced with 1. For
the IV-PSM procedure, we match on the logit of the IV propensity score, using an
optimal one-to-one match with a caliper of width equal to one fourth the standard
deviation of logit of the IV propensity scores. For information about caliper selection,
see Cochran and Rubin (1973), Raynor (1983), Rosenbaum and Rubin (1985), or
Austin (2011b).
We generate 1,000 datasets with binary outcome, treatment, and instrument for
i = 1, ..., n individuals from
P (Yi = 1|Di, X1i, X2i) = logit−1(βDi + δ1X1i + δ2X2i + Yi ),(2.10)
P (Di = 1|Zi) = logit−1(γ0 + γ1Zi + Di ),(2.11)
P (Zi = 1|X1i, X2i) = logit−1(ψ0 + ψ1X1i + ψ2X2i).(2.12)
(Y , D) are drawn from a bivariate normal with correlation 0.8 to represent unmea-
sured treatment-outcome confounding. X1 and X2 represent measured instrument-
outcome confounders and are randomly drawn from standard normal distributions.
β is varied from 0 to 1 and sample size is varied from 500 to 2,000. Results are
reported under the following parameter settings: ψ0 = γ0 = −1, ψ1 = δ1 = −0.25,
γ1 = 1 and ψ2 = δ2 = 0.25.
2.3.2 Results
Results for estimation and coverage properties of the estimators are reported in
Table 2.2. Each of the three estimators are found to be approximately unbiased. This
is expected because we have adjusted for instrument-outcome confounders X1 and
X2 in this simulation, and there are no unmeasured instrument-outcome confounders
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that would bias these IV methods. Coverage rates for each method are converging to
the nominal rate as sample size increases. Both weighted estimators have lower mean
squared errors (MSE) than IV-PSM, with the proposed IV-MW estimator achieving
the lowest MSE in each scenario. The 2:1 and 3:1 matching scenarios confirm that
the IV-MW estimator remains unbiased with the lowest MSE.
Table 2.2: Bias, MSE, and 95% coverage probabilities of IV-MW, IV-IPW, and IV-PSM for esti-
mation of λ. Reported results have been multiplied by 100.
Weighting Matching
IV-MW IV-IPW IV-PSM
k N β λ Bias MSE CP Bias MSE CP Bias MSE CP
1:1 500 0.0 0.00 -0.39 6.11 97.4 -0.51 6.38 97.2 0.50 12.53 97.2
0.5 0.12 -0.09 5.88 97.4 -0.38 6.17 97.1 1.05 9.42 98.2
1.0 0.22 -0.65 5.18 97.9 -0.40 5.50 97.4 -0.13 8.61 98.3
1:1 1000 0.0 0.00 0.16 2.59 96.2 0.27 2.62 96.2 0.69 4.14 96.5
0.5 0.12 0.42 2.50 96.9 0.67 2.57 96.5 0.70 3.84 97.0
1.0 0.22 0.31 2.17 97.0 0.81 2.32 96.5 1.19 3.59 96.8
1:1 2000 0.0 0.00 -0.04 1.28 95.6 -0.03 1.32 95.3 0.38 1.85 95.4
0.5 0.12 0.22 1.15 96.1 0.35 1.19 95.9 0.39 1.61 96.8
1.0 0.22 -0.71 1.26 95.2 -0.27 1.32 94.6 -0.19 1.87 95.5
2:1 2000 0.00 0.00 -0.10 1.25 96.1 -0.12 1.27 95.7 0.30 1.83 95.8
0.50 0.12 0.51 1.29 94.8 0.46 1.31 94.7 0.38 1.84 95.1
1.00 0.22 0.18 1.19 95.0 0.36 1.22 95.4 0.13 1.69 96.0
3:1 2000 0.00 0.00 -0.25 1.27 95.8 -0.31 1.27 96.3 -0.27 1.87 95.8
0.50 0.12 0.52 1.21 95.0 0.51 1.22 95.2 0.55 1.72 96.4
1.00 0.22 -0.05 1.16 95.7 -0.09 1.18 95.6 -0.16 1.65 97.5
A comparison of the estimated and empirical standard deviations in Table 2.3
confirms that the sandwich variance estimates (ASD) approximate the empirical
standard deviations (ESD) well. Applying the sandwich variance procedure to the
IV-PSM procedure requires that we ignore the matched nature of the data. While
this typically leads overestimation of the variance (Austin, 2009b, 2011a), this is not
seen to be an issue in the simulations reported here.
Additional simulations were performed to study the performance of the double
robust IV-MW estimator (IV-MWDR) of Section 2.2.2. For these simulations, the
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Table 2.3: Comparison of standard deviations obtained empirically (ESD) and using the sandwich
variance technique of Section 2.2.2 (ASD). Reported results have been multiplied by 100.
Weighting Matching
IV-MW IV-IPW IV-PSM
k N β λ ASD ESD ASD ESD ASD ESD
1:1 500 0.0 0.00 24.58 24.71 25.03 25.25 33.01 35.40
0.5 0.12 23.97 24.26 24.68 24.84 31.22 30.67
1.0 0.22 23.03 22.74 23.84 23.45 29.56 29.33
1:1 1000 0.0 0.00 16.37 16.08 16.62 16.19 20.06 20.35
0.5 0.12 16.06 15.79 16.32 16.02 19.76 19.59
1.0 0.22 15.40 14.74 15.79 15.21 19.03 18.91
1:1 2000 0.0 0.00 11.35 11.30 11.48 11.50 13.66 13.59
0.5 0.12 11.14 10.73 11.34 10.90 13.45 12.69
1.0 0.22 10.84 11.20 11.12 11.50 13.20 13.68
2:1 2000 0.0 0.00 11.27 11.20 11.52 11.29 13.74 13.52
0.5 0.12 11.00 11.35 11.31 11.43 13.42 13.54
1.0 0.22 10.67 10.90 11.03 11.02 13.07 12.99
3:1 2000 0.0 0.00 11.34 11.26 11.52 11.28 13.71 13.67
0.5 0.12 11.17 11.00 11.36 11.03 13.44 13.12
1.0 0.22 10.85 10.78 11.05 10.84 13.09 12.85
generating equations for Y and Z were redefined as
P (Yi = 1|Di, X1i, X2i) = logit−1(βDi + δ1X1i + δ2X2i + Yi +X1iX2i),(2.13)
P (Zi = 1|X1i, X2i) = logit−1(ψ0 + ψ1X1i + ψ2X2i +X1iX2i).(2.14)
The interaction term X1iX2i is ignored to represent an incorrectly specified model.
Results in Table 2.4 confirm that IV-MWDR provides consistent effect estimates
and maintains nominal coverage rates if at least one of the outcome or IV propensity
score models is correctly specified. The original IV-MW estimator only provides
consistent estimates when the IV propensity score model is correctly specified, and
its performance suffers greatly when this model is misspecified. An interesting finding
in Table 2.4 is that even though IV-MWDR requires the additional specification of an
outcome model, its performance is not damaged compared to IV-MW in situations in
which the double robust property would not be needed, i.e. when the IV propensity
score model is correctly specified. In other words, we do not lose anything, in terms
of bias or efficiency, by specifying the outcome model.
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Table 2.4: Estimation under correctly and incorrectly specified IV propensity score and outcome
models. n = 1, 000 and β = 1 for these simulations. Reported results have been
multiplied by 100.
Model Specification
P(Z) P(Y) Estimator % Bias MSE ASD ESD 95% CP
Correct Correct IV-MW -2.50 0.56 7.52 7.47 94.9
IV-MWDR -2.50 0.56 7.80 7.48 95.5
Correct Incorrect IV-MW -3.12 0.52 7.57 7.18 96.3
IV-MWDR -3.13 0.52 7.66 7.18 96.2
Incorrect Correct IV-MW 84.16 3.86 7.51 7.36 30.1
IV-MWDR -6.18 0.55 7.66 7.33 95.8
Incorrect Incorrect IV-MW 85.14 3.96 7.49 7.56 30.6
IV-MWDR 87.65 4.17 7.57 7.56 29.6
The simulations reported throughout this section demonstrate that the proposed
IV-MW estimator performs well compared with alternatives. It provided consistent
estimates, achieved the lowest MSE, and maintained approximately nominal coverage
in all scenarios reported. Both weighting estimators (IV-MW and IV-IPW) achieved
lower MSE than the matching estimator (IV-PSM), a result of allowing the full
data to contribute to estimation. The lower MSE for IV-MW compared with IV-
IPW could be because IV-IPW weights can “blow up” near probabilities of 0 or 1
(Li et al., 2014). While IV-MW weights are always bounded between 0 and 1, the
IV-IPW weights ranged from 1.05 to 20.5 in these simulations. Additionally, the IV-
MWDR estimator was able to protect against misspecification of the IV propensity
score model, providing consistent effect estimates if at least one of the IV propensity
score or outcome models were correctly specified. Both weighting estimators saw
computational benefits over IV propensity score matching as well. Using a MacBook
Pro with a 2 GHz Intel Core i7 processor, the following times (in seconds) were
observed to complete 1,000 simulations for n = 500, 1,000, and 2,000, respectively:
IV-MW - 6.3, 9.9, and 23.6, IV-IPW - 6.0, 9.4, and 21.4, IV-PSM - 65.4, 166.1,
and 547.9. While computing time was not a limiting factor in these simulations, it
quickly becomes one for matching estimators as sample size increases.
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2.4 Data Example
We illustrate use of the methods of this chapter with data from the United States
Renal Data System (USRDS) to study the association between dialysis session length
and mortality among incident hemodialysis patients in the United States. Longer
dialysis sessions are thought to decrease mortality by reducing the risk of intradialytic
hypotension and better controlling volume excess and serum phosphorous (Daugir-
das, 2013), but this relationship is likely confounded. Shorter dialysis sessions are
often prescribed to smaller patients, and smaller patients tend to have higher mor-
tality rates, so direct comparisons would likely give biased effect estimates. Many
observational studies have found a significant increase in mortality in patients re-
ceiving shorter dialysis sessions (Flythe et al., 2013; Saran et al., 2006). A 2002
randomized trial, on the other hand, found no significant relationship between dial-
ysis session length and mortality (Eknoyan et al., 2002), and Brunelli et al. (2010)
found longer dialysis sessions to be associated with higher or lower mortality de-
pending on whether the treatment was considered time dependent. These conflicting
results suggest that unmeasured treatment-outcome confounding may be present and
an IV analysis may provide new and useful insight.
We obtained complete data on 319,168 adults initiating hemodialysis (HD) be-
tween January 1, 2010 and December 31, 2013 from the USRDS database. We
restricted the analysis to patients on a thrice-weekly dialysis schedule (98% of all
incident HD patients in the data were on a thrice-weekly dialysis schedule). We
conducted an intention-to-treat analysis, defined the treatment as being prescribed
dialysis sessions of four hours or longer, and defined the outcome as death within the
first year after initiating dialysis. Mean treatment usage in the hospital service area
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(HSA) from 2007 to 2009 was used as the IV (Figure 2.3). The HSA is a geographic
region representing a collection of zip codes with residents that receive most of their
healthcare within that region (Dartmouth, 2016). Preference-based instruments such
as this one are among the most common in health research (Garabedian et al., 2014),
and are thought to measure treatment preferences that are independent of patient
level confounders (Brookhart and Schneeweiss, 2007; Li et al., 2015).
Among the 3,336 HSAs in the data, mean treatment usage varied from 0 to 100%
with a mean of 74%. The correlation coefficient between the mean treatment usage
from 2007-2009 and mean treatment usage from 2010-2013 in an HSA was almost
90%. This indicates that preferences in an HSA are relatively stable through time,
and that mean treatment usage in an HSA from 2007-2009 is a strong instrument for
treatment in the 2010-2013 data. To fit the methods of this chapter, we dichotomized
the instrument by considering HSAs with above average treatment usage to be en-
couraging subjects toward longer dialysis sessions and HSAs with below average
usage to be encouraging their subjects toward shorter dialysis sessions.
The distribution of covariates by treatment and instrument groups is reported in
Table 2.5. Patients receiving longer dialysis sessions tend to have higher BMI and are
more likely to be male, black, and younger compared with patients receiving shorter
dialysis sessions. These patients are also more likely to receive dialysis at for profit
facilities in poorer, less educated areas. Comparing across instrument groups greatly
improves the balance of covariates. This is evidence that mean treatment usage in
an HSA may serve as a valid IV, although some imbalances remain in facility and
zip code level variables.
We first fit unadjusted and covariate adjusted logistic regression models to com-
pare with the IV methods of this chapter. These suggest a significant decrease in
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Figure 2.3: Distribution of longer dialysis session usage by hospital service area (HSA). Longer
dialysis sessions are defined as being prescribed dialysis sessions of four or more hours.
the odds of first year mortality among patients with longer dialysis sessions, with
estimated odds ratio and 95% confidence intervals of 0.86 (0.84, 0.87) and 0.95 (0.93,
0.97), respectively. Age, sex, race, ethnicity, BMI, number of comorbidities, access
type, profit status of the facility and median income in the zip code were included
in the covariate adjusted model. These logistic regressions will be biased if there are
confounders between the treatment and the outcome that are not included in the
model.
To implement the methods of this chapter, we begin by modeling the IV propen-
sity score, or the probability of being in an HSA with above average usage of longer
dialysis sessions. We specify a logistic regression model and include HSA level covari-
ates mean age, BMI, number of comorbidities, percentage of males, blacks, hispanics,
and patients without insurance, and median income, as well as patient level covari-
ates age, sex, race, and BMI. Using the estimated IV propensity score, a weight is
assigned to each subject for the IV-MW and IV-IPW procedures. For the IV-MW
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Table 2.5: Distribution of covariates across treatment (long vs short dialysis sessions) and instru-
ment groups (high vs low treatment usage at HSA level). Reported in the table is the
mean and absolute standardized difference, d, between groups. An absolute standardized
difference of more than 10 is generally considered to indicate an imbalance (Love, 2002).
Hours on Dialysis Usage in HSA
< 4 ≥ 4 d Low High d
Treatment
4+ hour sessions - - - 60.3% 88.8% 69.1
Outcome
Death w/in 1st year 23% 21% 6.2 22% 21% 0.8
Patient Level Covariates
Age 65.9 63.0 19.6 64.3 63.3 6.8
Male 51% 59% 16.7 57% 56% 2.1
BMI 28.0 30.4 28.2 29.4 30.1 8.3
Serum Creatinine 6.4 6.7 1.6 6.7 6.6 0.3
Hemoglobin 10.0 9.9 0.7 9.9 9.9 0.1
Black 23% 31% 16.6 26% 32% 12.4
Hispanic 17% 14% 8.4 17% 11% 10.9
Pre-ESRD 6+ Months 41% 44% 5.6 41% 45% 8.3
Employed 8.3% 9.1% 3.0 9.1% 8.8% 0.9
No Insurance 5% 8% 10.9 6% 8% 10.3
# Comorbidities 2.5 2.6 5.4 2.5 2.6 5.7
Facility Level Covariates
# Nurses 7.3 7.3 0.3 7.7 7.0 12.2
# Patient techs 8.9 8.8 1.1 9.1 8.5 8.1
# HD stations 20.8 21.7 10.2 21.2 21.7 5.7
For profit 81% 86% 14.9 82% 88% 16.5
Zip Code Level Covariates
Median income $54,551 $49,286 25.3 $53,358 $47,960 26.9
Bachelors degree + 25.5% 22.9% 18.0 24.6% 22.6% 14.9
procedure, this weight is given in (2.4). For the IV-IPW procedure the weight is
defined similar to (2.4), but with the numerator replaced with 1. For the IV-PSM
procedure, we specified a one-to-one optimal match on the IV propensity score with
a caliper of 0.05.
Table 2.6: Instrumental variable estimates and 95% confidence intervals for the effect of longer dial-
ysis sessions on first year mortality. Negative estimates suggest less first year mortality
among the patients receiving longer dialysis sessions.
λˆ 95% CI
IV-MW -0.015 (-0.028, -0.002)
IV-IPW -0.006 (-0.018, 0.006)
IV-PSM -0.015 (-0.028, 0.001)
The results in Table 2.6 suggest a small protective effect of longer dialysis sessions.
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These IV results corroborate those found with the logistic regression models, although
the estimated effects appear smaller and are insignificant for the IV-IPW and IV-
PSM procedures. These estimates can be interpreted as follows; for λˆ = −0.015, for
example, we expect 1.5 less deaths in the first year for every 100 patients that could
be encouraged to take long dialysis sessions. Note that IV-MW and IV-PSM gave
similar results, with IV-MW obtaining a narrower confidence interval. This agrees
with the idea that the IV-MW estimator is a more efficient approximation to the
IV-PSM process.
2.5 Future Work
The IV-MW estimator proposed in this chapter was developed for use with binary
outcomes. In this section, we present preliminary work on developing the IV-MW
estimator for use with time-to-event or survival data. Given the importance of sur-
vival data in public health and medical studies, this work has the potential for broad
applications in research. Few IV methods have been extended to survival data thus
far. Terza et al. (2008) discuss the use of two stage residual inclusion, an extension
of two stage least squares, with a Weibull regression for modeling survival data. Li
et al. (2015) develop a two stage estimator of causal effects assuming an additive
hazards model.
In this preliminary work, we modify the IV-MW procedure to estimate the dif-
ference in restricted mean survival between treatment groups in the presence of
unmeasured confounding. We develop the method under both independent and in-
formative censoring schemes. We report simulations to study its performance, and
apply it to the data example of Section 2.4.
Restricted mean survival is the expected survival time for an individual over a fixed
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period of time. While we currently focus on estimating the difference in restricted
mean survival, further work on estimating other parameters relevant to survival data
is warranted.
Methods
As in Section 2.2.2, define the IV-matching weight for subject i as
(2.15) Wi =
min(e(xi), 1− e(xi)
Zie(xi) + (1− Zi)(1− e(xi)) ,
where e(xi) is the IV propensity score conditional on covariates xi. We assume that
we observe event times Yi = Ri ∧ Ci, where R represents the time to response and
C represents the time to censoring. Let δi = I(Ri < Ci) indicate observing the
response for subject i, and let tz1, t
z
2, ..., t
z
kz
be distinct event times for instrument
groups Z = 0, 1. Finally, let Di indicate treatment received for subject i.
IV-MW with Independent Censoring
We first present the estimator under the assumption that censoring times are
independently distributed. Define the weighted number of observed responses in
group Z at time tzj as
(2.16) dzj =
n∑
i=1
WiδiI(Yi = t
z
j , Zi = z)
and the weighted number of individuals at risk in group Z at time tzj as
(2.17) nzj =
n∑
i=1
WiI(Yi ≥ tzj , Zi = z).
Mean survival is then estimated as
(2.18) µˆzY =
tkz∑
t=1
Sˆz(t),
where
(2.19) Sˆz(t) =
t∏
j=1
(
1− d
z
j
nzj
)
.
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This is simply the area under a weighted, or adjusted, Kaplan-Meier curve (Kaplan
and Meier, 1958; Xie and Liu, 2005), where each individual is weighted by their
IV-matching weight, Wi.
Define the mean treatment usage in group Z as
(2.20) µˆzD =
1
n
n∑
i=1
WiDiI(Zi = z).
Finally, define the estimate of interest as
(2.21) ∆ˆIV-MW =
µˆ1Y − µˆ0Y
µˆ1D − µˆ0D
.
Similar to the estimator in (2.1), this represents the ratio of the instrument’s
effect on survival to the instrument’s effect on the treatment. Further research on
this estimate and how the assumptions of Section 2.2.2 apply here is needed.
IV-MW with Informative Censoring
Assuming that censoring times are distributed independently of survival times is
often unrealistic in practice. More often, there are covariates that affect both the
censoring and survival time distributions. This is known as informative censoring,
and if ignored can lead to biased effect estimates. Robins and Finkelstein (2000)
proposed inverse probability of censoring weighting to handle informative censoring.
In this section, we show how the estimator developed for independent censoring can
be easily extended for use under informative censoring schemes by combining the
IV-matching weight with inverse probability of censoring weights.
Assume that we measure covariates xc,i that affect the censoring and survival time
distributions. Define the inverse probability of censoring weights as
(2.22) WCi,j =
1
GˆC(tj)
,
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where GˆC(tj) is a Cox regression model used to model the probability of being
censored, given as
(2.23) GˆC(tj) = λˆC(tj)exp(βˆ
′
CxC,i),
where λˆC(tj) represents the baseline hazard at time tj. We fit separate Cox regression
models to the censoring times in the Z = 0 and Z = 1 groups. With these weights,
we redefine the weighted number of observed responses and individuals at risk in
group Z at time tzj as
(2.24) dzj =
n∑
i=1
WiW
C
i,jδiI(Yi = t
z
j , Zi = z)
and
(2.25) nzj =
n∑
i=1
WiW
C
i,jI(Yi ≥ tzj , Zi = z).
dzj and n
z
j in (2.24) and (2.25) are similar to those defined for the independent cen-
soring case in (2.16) and (2.17), though here individuals are weighted by the prod-
uct of their matching weight Wi and their censoring weight W
C
i , rather than only
their matching weight, at each time point. With dzj and n
z
j appropriately redefined,
µˆzY , Sˆ
z(tzj),, µˆ
z
D, and ∆ˆIV-MW are estimated as before.
Simulation
In this section we report simulation results to investigate the performance of the
modified IV-MW estimator for estimating the difference in mean 5-year survival.
We generate 1,000 datasets, each with n subjects. Instrument Z is generated from a
Bernoulli distribution with
(2.26) logit(p(Z = 1)) = γ + 0.25x1 + 0.25x2,
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where γ, x1 and x2 are randomly generated from a N(0, 1) distribution. Covariates
x1 and x2 represent instrument-outcome confounders and will be used in a logistic
regression for modeling the IV propensity score. Treatment D is drawn from a
Bernoulli distribution as well, with
(2.27) logit(p(D = 1)) = −0.5 + Z + 0.5xu,
where xu ∼ N(0, 1) represents an unmeasured confounder between the treatment
and the survival time.
We simulate data under both independent and informative censoring schemes.
For independent censoring, censoring times are randomly drawn from a uniform
distribution between 1 and 1,825 days (5 years) and survival times are are drawn
from an exponential(λ/100) distribution with
(2.28) λ = −1.5 + βD + 0.25x1 + 0.25x2 + 0.5xu.
For informative censoring, censoring times are randomly drawn from an exponential(η/100)
distribution, with
(2.29) η = −3 + xc,
where xc ∼ N(0, σ2c ). Survival times are then randomly drawn from an exponential(λ/100)
distribution with
(2.30) λ = −1.5 + βD + 0.25x1 + 0.25x2 + 0.5xu + 0.25xc.
Approximately 25% of individuals are censored under these settings.
We set β = 0 throughout these simulations, so that the treatment has no effect
on survival time. We compare estimation of the difference in 5-year restricted mean
survival using the following four procedures:
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IV-MW: Difference in restricted mean survival is calculated between instrument
groups, Z = 0, 1, and measured instrument-outcome confounders x1 and x2 are ad-
justed for using the IV-matching weight procedure proposed in this chapter. This
method is expected to overcome potential bias arising from both unmeasured con-
founder xu and measured instrument-outcome confounders x1 and x2.
IV-PSM: Difference in restricted mean survival is calculated between instru-
ment groups, Z = 0, 1, and measured instrument-outcome confounders x1 and x2
are adjusted for by first matching on the IV propensity score. Similar to IV-MW,
this method is expected to overcome potential bias arising from both unmeasured
confounder xu and measured instrument-outcome confounders x1 and x2.
IV: Difference in restricted mean survival is calculated between instrument groups,
Z = 0, 1. While this approach helps overcome bias arising from unmeasured con-
founder xu, it will fail to adjust for measured instrument-outcome confounders x1
and x2. This violates the assumption that the instrument is randomly assigned, and
therefore is expected to give biased estimates.
NAIVE: Difference in restricted mean survival is calculated between treatment
groups, D = 0, 1. This naive approach is expected to give biased estimates due to
unmeasured confounder xu.
Inverse probability of censoring weights are applied to each procedure for the infor-
mative censoring scenario, with covariate xc used in the Cox models for determining
the censoring weights. Confidence intervals are obtained through bootstrapping,
though further research related to variance estimation for the estimator is needed.
Simulation results in Table 2.7 show that the IV-MW estimator generally out-
performs each of the remaining three estimators. IV-MW and IV-PSM maintained
approximately nominal coverage rates, though IV-MW was less biased than IV-PSM
34
Table 2.7: Estimation of difference in 5-year restricted mean survival (in days) and 95% coverage
probabilities for each method. Coverage probabilities are based on bootstrapped confi-
dence intervals with 500 bootstrap iterations. In simulated data, there was no effect of
treatment and no difference in mean survival is expected. Results are based on 1,000
simulations.
IV-MW IV-PSM IV NAIVE
Censoring ∆ n ∆ˆ CP ∆ˆ CP ∆ˆ CP ∆ˆ CP
Independent 0 500 -12 94.5 -18 95.5 -202 83.8 -96 53.6
1,000 -1 95.2 -18 94.1 -192 76.3 -98 23.1
2,000 -2 93.7 -20 94.2 -196 58.0 -98 4.5
5,000 -2 94.3 -24 93.6 -194 21.2 -98 0.1
Informative 0 500 15 94.3 -2 93.5 -178 84.1 -98 48.1
1,000 -9 94.5 -33 94.1 -201 73.2 -98 22.5
2,000 2 95.1 -30 94.4 -190 56.3 -97 2.9
5,000 1 95.2 -36 92.5 -192 22.8 -98 0.0
in seven of the eight scenarios compared. As expected, the IV and Naive procedures
found severely biased estimates and poor coverage rates. No major differences are
seen when comparing methods across the independent and informative censoring
scenarios, suggesting that the inverse probability of censoring weights are able to
overcome any problems arising from the informative censoring.
Data Example
We reexamine the data example of Section 2.4 using the methods of this section.
Previously, we compared mortality and dialysis session length using death within the
first year after initiating dialysis. In that analysis, we converted a survival outcome
(time to death) into a binary outcome (death within one year). Using the methods
of this section, we are able to study mortality and dialysis session length using the
original time to death outcome. We censor all individuals at either one, two, or five
years and estimate difference in restricted mean survival.
Results in Table 2.8 suggest that patients with longer dialysis sessions generally
have longer one-, two-, and five-year restricted mean survival times. The relatively
large estimates for the NAIVE procedure could be a result of unmeasured differences
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Table 2.8: Estimated difference in restricted mean survival (in days) between patients with longer
versus shorter dialysis sessions lengths. 95% confidence intervals were obtained through
bootstrapping with 500 bootstrap iterations.
1 Year 2 Year 5 Year
Model ∆ˆ (95% CI) ∆ˆ (95% CI) ∆ˆ (95% CI)
IV-MW 5.2 (2.2, 8.2) 11.7 (3.3, 19.0) 28.9 (0.8, 53.7)
IV-PSM 5.6 (2.4, 9.4) 11.4 (3.6, 19.7) 27.1 (-2.8, 53.9)
IV 2.2 (-0.2, 4.4) 2.9 (-2.6, 9.2) -1.3 (-21.5, 14.4)
NAIVE 6.2 (5.5, 7.1) 17.0 (15.0, 19.0) 71.7 (65.4, 77.7)
between patients receiving longer or shorter dialysis sessions. The three IV models
found greatly attenuated effects, and in some cases estimates that are statistically
insignificant at the 0.05 level. The similar estimates for the IV-MW and IV-PSM
procedures, with IV-MW finding narrower 95% confidence intervals, confirms that
IV-MW is a more efficient approximation to the IV-PSM process. Qualitatively, the
results Table 2.8 agree with those of Section 2.4, which also suggested that patients
with longer dialysis sessions had decreased mortality.
2.6 Discussion
A key assumption in instrumental variable analyses is that the instrument is ran-
domly assigned, which requires that there are no unmeasured confounders between
the instrument and the outcome. Unfortunately, unless the instrument is based on
actual randomization, this assumption is unlikely to hold without conditioning on
a set of known, measured confounders. The researcher must then argue that the
instrument is distributed as good as random after controlling for these instrument-
outcome confounders. Garabedian et al. (2014) emphasize that the most commonly
used instruments have potential instrument-outcome confounders associated with
them and that failing to adjust for these confounders can bias estimation.
In this work we developed a weighted IV estimator based on the IV propensity
score to adjust for instrument-outcome confounders. The weights reflected the prob-
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ability that an individual would be selected into a one-to-one IV propensity score
match, and modified weights for approximating k:1 matching designs were provided
as well. We further presented a double robust version of the estimator that protects
against misspecification of the IV propensity score model. Though this required the
additional specification of an outcome model, the double robust estimator provided
consistent estimates if only one of the outcome or IV propensity score models was
correctly specified, but did not require both to be correct.
One-to-one IV propensity score matching involves pairing each encouraged sub-
ject to an unencouraged subject with a similar IV propensity scores, often within
a specified range. If a match cannot be found within this range, pairing the en-
couraged subject with an unencouraged subject with a substantially different IV
propensity score can bias estimation, whereas removing that subject from the anal-
ysis leads a loss of efficiency. The proposed estimator avoids these pitfalls, leading
to more efficient estimation as every individual contributes. Additional benefits over
matching include straightforward variance estimation and computational efficiency.
Through simulation, the proposed estimator was found to outperform alternatives,
being equally unbiased with uniformly smaller mean squared errors.
Preliminary work related to extending the IV-MW procedure of this chapter for
use with time-to-event or survival data suggested that the IV-MW procedure is useful
for obtaining consistent survival estimates in the presence of unmeasured confound-
ing. We discussed estimating the difference in restricted mean survival using the
IV-MW procedure and showed that it performed well in simulation. Further work
on this topic includes understanding how the assumptions of Section 2.2.2 apply in
this context, how to accurately estimate variance of the estimator, and the possibility
of estimating other parameters relevant to survival studies. Given the importance of
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survival data in public health and medical research, extending the IV-MW estimator
for use with these data can have broad applications.
Implementation of these methods were illustrated using USRDS data to study the
association between dialysis session length and first year mortality among hemodial-
ysis patients in the United States. While longer dialysis sessions are thought to
decrease risk of mortality, it is a difficult research question as the relationship be-
tween session length and mortality is likely confounded, as smaller patients with
higher mortality risk are more likely to be prescribed shorter dialysis sessions. This
might explain the lack of consensus among previous studies. Using the IV methods
of this article, a small protective effect of longer dialysis sessions was found, suggest-
ing 1.5 fewer first year deaths for every 100 dialysis patients encouraged to switch
from shorter to longer dialysis sessions. These findings corroborate the findings from
covariate adjusted logistic regression models, although estimates were smaller and
insignificant for some IV models. Applying the IV-MW estimator modified for use
with survival data similarly suggested that patients with longer dialysis sessions had
longer one-, two-, and five-year restricted mean survival times.
In the next chapter we focus on the strength of correlation between the instrument
and the treatment, and propose a method for increasing this strength. Instruments
with little influence over the treatment are termed weak instruments, and there are
several problems associated with them. They suffer from greater finite-sample bias
and variability in estimation. Additionally, results obtained using weak instruments
are less robust to unmeasured instrument-outcome confounders (Bound et al., 1995;
Small and Rosenbaum, 2008). These benefits have motivated methods for increasing
the strength of instrumental variables.
CHAPTER III
Strengthening Instrumental Variables Through Weighting
3.1 Motivation
The most common instrumental variables have potential confounders associated
with them that, when left unmeasured, violate the assumption that the instrument
is randomly assigned and can bias estimation. In the previous chapter we developed
an IV estimator that adjusted for measured confounders between the instrument and
the outcome. Adjusting for these confounders helps to argue that the instrument is
conditionally distributed “as good as random.”
Unfortunately, this assumption cannot be verified to hold and is likely to be
criticized even after controlling for a number of measured covariates. It is therefore
good to have results that are sufficiently robust to violations of it. One approach to
obtaining more robust results is to work with stronger instruments. The strength
of the instrument refers to the strength of the relationship between the instrument
and the treatment. Instruments that have low correlation with the treatment are
referred to as weak instruments and are known to have poor properties (Bound et al.,
1995; Small and Rosenbaum, 2008). They have more finite-sample bias and greater
variability in estimation. Additionally, results obtained using weak instruments are
particularly sensitive to violations of the assumption that the instrument is randomly
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assigned. These benefits have motivated recent methods for increasing the strength
of instrumental variables (Baiocchi et al., 2010, 2012). In this chapter, we propose a
novel weighting procedure for strengthening instrumental variables.
The literature relating to weak instrumental variables has primarily focused on
detailing the problems and limitations associated with using them. See, for exam-
ple, Bound et al. (1995), Staiger and Stock (1994), Angrist et al. (1996), Small and
Rosenbaum (2008) or Baiocchi et al. (2014). Variable selection methods to select
a strong subset among a pool of weak instruments have been proposed in Belloni
et al. (2010), Caner and Fan (2010), and Belloni et al. (2012). For working with a
single weak instrument, Baiocchi et al. (2010) proposed near-far matching, a novel
method to extract a smaller study with a stronger instrument from a larger study
(see also Baiocchi et al. (2012) or Zubizarreta et al. (2013)). This matching-based
IV methodology aims to construct pairs that are “near” on covariates but “far” in
the instrument. In other words, pairs consist of subjects with similar characteris-
tics who have received substantially different amounts of encouragement toward the
treatment, with a greater difference indicating a stronger instrument. This differ-
ence is increased in the near-far matching procedure through the use of penalties to
discourage individuals with similar instrument values from pairing, while allowing a
certain number of individuals to be removed from the analysis entirely. This results
in a stronger instrument across a smaller number of pairs. One limitation of near-far
matching is that it may strengthen the instrument at the cost of match quality.
We propose weighted IV-matching, an alternative for strengthening the instru-
ment within this IV-matching framework. Rather than using penalties to discourage
individuals that receive similar encouragement from pairing, we propose strengthen-
ing the instrument after matches have been formed through weighting, with a pair’s
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weight being a function of the instrument within that pair. A fundamental difference
between these two techniques is the stage at which the instrument is strengthened.
Weighted IV-matching strengthens the instrument after matches have been formed,
allowing the matching algorithm to focus on creating good matches with similar co-
variate values. Near-far matching, on the other hand, strengthens the instrument
and matches on covariates simultaneously, requiring the algorithm to share priority
between these two goals. This generally leads to better quality matches for weighted
IV-matching, a major benefit since failing to properly match on important covariates
may lead to bias in estimation.
We illustrate these methods with a comparison of hemodialysis (HD) and peri-
toneal dialysis (PD) on six-month mortality among patients with end stage renal
disease (ESRD) using data from the United States Renal Data System (USRDS).
PD has several benefits over HD, including cost benefits, an improved quality of
life, and the preservation of residual renal function (Marro´n et al., 2008; Tam, 2009;
Goodlad and Brown, 2013). Despite this, PD remains underutilized in the United
States (Jiwakanon et al., 2010). One explanation for this may be a lack of consensus
regarding the effect of PD on patient survival. A randomized trial investigating this
question was stopped early due to insufficient enrollment (Korevaar et al., 2003).
Many observational studies have suggested that PD is associated with decreased
mortality, though results are often conflicting (Heaf et al., 2002; Vonesh et al., 2006;
Weinhandl et al., 2010; Mehrotra et al., 2011; Kim et al., 2014; Kumar et al., 2014).
Complicating comparisons of HD and PD patients is a strong selection bias, with
PD patients tending to be younger and healthier than HD patients. Studies have
dealt with this issue by measuring and controlling for important confounders, but
to our knowledge none have addressed the possibility of unmeasured confounding
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that likely remains. We define PD as the treatment and consider a binary outcome
for six-month survival. The focus on six-month survival is to study the influence
of initial dialysis modality on early mortality, which tends to be high for dialysis
patients. Studying early mortality can provide guidance for selecting the initial dial-
ysis modality in order to reduce this early mortality. See, for example, Noordzij and
Jager (2012), Sinnakirouchenan and Holley (2011), or Heaf et al. (2002).
A possible instrument in the data is the mean PD usage at the facility level.
Instruments based on mean treatment usage in a geographic region, facility, or other
group are often called preference-based instruments (Brookhart and Schneeweiss,
2007; Li et al., 2015), because it is believed that these groups may have preferences
that at least partially override both measured and unmeasured patient characteristics
when making treatment decisions. In other words, facilities with high PD usage are
more likely to “encourage” their patients towards PD than those with low usage.
Preference-based instruments are among the most commonly used instruments in
practice (Garabedian et al., 2014), and methods to improve them may have broad
applications.
The remainder of this chapter is organized as follows. In Section 3.2 we outline
the proposed weighted IV-matching procedure and briefly compare it to near-far
matching. Inference and sensitivity are discussed in Section 3.3. The finite sample
performance of these methods are compared in Section 3.4 through simulation, and
they are illustrated with a data analysis in Section 3.5. We conclude with a discussion
in Section 3.6.
42
3.2 Methods
We begin this section with an outline of the IV matching framework presented in
Baiocchi et al. (2010, 2012) and then propose a weighting procedure for strengthening
the instrument within this framework. We briefly compare the proposed weighting
procedure with near-far matching and highlight key differences.
With a preference-based instrument, two rounds of matching are implemented
(Baiocchi et al., 2012). In the context of our motivating data example, an optimal
non-bipartite matching algorithm first pairs facilities (Derigs, 1988; Lu et al., 2011).
After facilities have been paired, the instrument is dichotomized into encouraging and
unencouraging. This is done by comparing instrument values within each facility pair
and considering the facility with the higher value to be an encouraging facility and
the other to be an unencouraging facility. An optimal bipartite matching algorithm
then pairs patients at the PD encouraging facility with patients in the other. This
results in I pairs of two subjects with similar patient and facility characteristics that
received different levels of encouragement toward PD. Instrument strength can be
assessed by the average difference, or separation, of this encouragement across pairs.
For example, the instrument is considered stronger in a study in which the average
encouraged and unencouraged subjects were treated at facilities with 85% and 30%
treatment usage compared to one with average treatment usage of 60% and 45%.
Creating a stronger instrument in this framework is thus equivalent to increasing
this separation. We propose increasing this separation by assigning more weight to
pairs that are more influenced by the instrument. Specifically, we propose weighting
by the probability that the encouraged subject receives the treatment while the
unencouraged subject receives the control. This can be thought of as the probability
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that a pair “complies” with encouragement, and giving more weight to pairs more
likely to comply creates a stronger instrument across all pairs. Without loss of
generality, assume that subject j in pair i was treated at the encouraging facility
and subject j′ at the unencouraging facility, with Zij = 1 indicating encouragement
and Zij′ = 0 indicating unencouragement. Let Dij indicate treatment received. The
weight for pair i is then defined as
(3.1) wi = P (Dij = 1|Zij = 1)P (Dij′ = 0|Zij′ = 0).
Similar to separation of the instrument, this probability is a measure of instrument
strength, though rather than an average across all pairs it is a measure of the influence
of the instrument within pair i. A stronger instrument is created when more weight
is given to pairs in which the instrument has more influence over treatment. This
has the effect of redistributing the data in a way that highlights “good” pairs that
are more influenced by the instrument and increasing separation of the instrument
in the process.
In practice, the probabilities in equation (3.1) are unlikely to be known but
will need to be estimated. Using facility level mean PD usage as the instrument,
P (Dij = 1|Zij = 1) is estimated by the mean PD usage at the encouraging facility,
while P (Dij′ = 0|Zij′ = 0) is estimated with one minus the mean PD usage at the
unencouraging facility. Weights can be standardized to maintain the effective sample
size and statistical power if necessary.
The near-far matching procedure of Baiocchi et al. (2010, 2012) forces separation
of the instrument in the matching process. This is done in the first round by adding a
penalty to the distance measure between facilities whose instrument values are within
a certain threshold, and allowing a certain number to be removed. This requires the
matching algorithm to pair facilities with similar covariates and enforce separation of
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encouragement simultaneously, and generates an implicit tradeoff. A large penalty
will dominate the distance used to reflect similarity on covariates, thereby increasing
instrument separation but at the expense of match quality, whereas a small penalty
may get overshadowed by the covariate distance, leading to better matches, but
with less separation. Removing a number of facilities serves to alleviate some of the
damage to match quality that arises when requiring the matching algorithm to share
priority between creating good matches and enforcing instrument separation.
A fundamental difference between weighted IV-matching and near-far matching is
the stage in which the instrument is strengthened. Weighted IV-matching strength-
ens the instrument after matches have been formed, which allows the matching algo-
rithm to focus solely on creating good matches with similar covariate values. Near-far
matching, on the other hand, strengthens the instrument in the matching process,
forcing the algorithm to balance creating good matches and enforcing separation of
the instrument. This difference highlights a theme that we will see when comparing
the performance of these two methods; in a tradeoff between match quality and in-
strument strength, weighted IV-matching tends to favor match quality while near-far
matching tends to favor instrument strength. Strength in either of these areas has
implications on the resulting analysis.
3.3 Inference
3.3.1 Notation
We return to the potential outcomes notation presented in Section 2.2 of Chapter
II for defining causal effects. Let Zij = 1 if subject j in pair i is encouraged toward
treatment, Zij = 0 otherwise. Let Dij(Zij) indicate treatment received for subject
j in pair i given their encouragement, and let Yij(Zij, Dij(Zij)) indicate mortality.
Dij(Zij) and Yij(Zij, Dij(Zij)) are referred to as a subjects “potential outcomes.”
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For encouraged subjects, with Zij = 1, we observe treatment Dij(1) and response
Yij(1, Dij(1)). Similarly for unencouraged subjects, we observe Dij(0) and response
Yij(0, Dij(0)). Our interest lies in estimating the parameter
(3.2) λ =
∑
i
∑
j (Yij(1, Dij(1))− Yij(0, Dij(0)))∑
i
∑
j (Dij(1)−Dij(0))
.
This parameter is often referred to as the local average treatment effect (Imbens
and Angrist, 1994; Angrist et al., 1996). In contrast to an average treatment effect,
which is applicable to the entire population, the local effect is interpreted as an
average treatment effect among a subgroup of the population known as “compliers.”
Depicted in Table 2.1, compliers are individuals that will take the treatment that
they are encouraged to take.
3.3.2 Assumptions
Unfortunately, subjects are never observed under both states of encouragement,
and we thus never observe both Yij(1, Dij(1)) and Yij(0, Dij(0)) or both Dij(1) and
Dij(0) and must estimate λ from the data. We impose the following five assumptions
to aid us in estimation (Angrist et al., 1996; Baiocchi et al., 2014). We list them
briefly here, but a more thorough discussion of these assumptions can be found in
Section 2.2.
A1. Stable Unit Treatment Value Assumption (SUTVA).
A2. Random assignment of the instrument.
A3. Exclusion Restriction.
A4. Nonzero association between instrument and treatment.
A5. Monotonicity.
Assumptions A1 and A2 allow for unbiased estimation of λ. Adding assumptions
it A3-A5 restricts the applicability of λ to the subgroup of compliers (Table 2.1).
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Further discussion of these assumptions can be found in Section 2.2, as well as
Imbens and Angrist (1994), Angrist et al. (1996), Baiocchi et al. (2014).
3.3.3 Estimation
Denote the observed response and treatment for subject j in pair i as Yij =
ZijY (1, Dij(1)) + (1 − Zij)Y (0, Dij(0)) and Dij = ZijDij(1) + (1 − Zij)Dij(0), re-
specively. Estimate λ as
(3.3) λˆ =
∑I
i=1 wˆi
∑2
j=1 [ZijYij − (1− Zij)Yij]∑I
i=1 wˆi
∑2
j=1 [ZijDij − (1− Zij)Dij]
.
For inferences regarding λ, Baiocchi et al. (2010) developed an asymptotically
valid test for the null hypothesis H
(λ)
0 . H
(λ)
0 is true under many population distribu-
tions, and therefore is a composite null hypothesis. The size of a test for a composite
null is the supremum over all null hypotheses in the composite null, and a test is
considered valid if it has size less than or equal to its nominal level. Using statistics
T (λ0) =
1
I
I∑
i=1
wˆi
[
2∑
j=1
Zij(Yij − λ0Dij)−
2∑
j=1
(1− Zij)(Yij − λ0Dij)
]
=
1
I
I∑
i=1
Vi(λ0)
and
S2(λ0) =
1
I(I − 1)
I∑
i=1
[Vi(λ0)− T (λ0)]2,
we can test H
(λ)
0 by comparing T (λ0)/S(λ0) to a standard normal cumulative distri-
bution for large I. Inverting this test and solving for T (λ0)/S(λ0) = 0 and ± 1.96
provides an estimate and 95% confidence interval for λ. A detailed discussion of this
statistic, its distribution, and related issues can be found in Baiocchi et al. (2010).
This inference procedure provides a confidence interval for the estimate but unfor-
tunately it does not provide a standard error. To obtain a standard error estimate, we
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implement the sandwich variance procedure of Section 2.2. In Sections 3.4 and 3.5,
intervals and coverage results will be based on the permutation inference procedure.
3.4 Simulation
In this section we compare the finite sample performance of three IV-matching
techniques through simulation. The standard IV-match (IVM) uses the full data
and makes no attempt to strengthen the instrument, while weighted IV-matching
(WIVM) and near-far matching (NFM) will strengthen the instrument as described
in section 3.2. For the NFM procedure, we add a penalty to the distance between
facilities if their instruments are within a distance equal to the interquartile range of
instrument values. As in Baiocchi et al. (2010), we specify a penalty function that
begins at 0 and increases exponentially a pairs instrument values become closer, and
allow 50% of facilities to be removed during the matching process.
3.4.1 Setup
One thousand datasets are generated containing i = 1, ..., 200 facilities with j =
1, ..., 40 subjects at each. Binary treatment D and binary outcome Y are randomly
assigned with
(3.4) P (Dij = 1) = logit
−1(γi + αX1,i + δX2,ij + νij),
(3.5) P (Yij = 1) = logit
−1(βDij + αX1,i + δX2,ij + ij).
γi ∼ N(0, 1) represents a facility effect. Standard normal covariates X1,i and X2,ij
represent observed confounders and are used for matching. X1,i is a facility level
confounder and X2,ij is a patient level confounder. Coefficients α, δ, and β represent
the effects of X1, X2, and D, respectively. Unobserved confounding is created by
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generating (νij, ij) as bivariate normal with correlation ρ = .75. The proportion of
treated individuals at each facilities serves as the instrument.
To obtain the “true” local average treatment effect that we wish to estimate, or
λ in (3.2), we need counterfactual treatments and responses for every individual.
These are not easily obtained under the current setup, since γ, not encouragement,
is in equation (3.4). Furthermore, we do not know which counterfactual state an
individual will be considered to have been observed in until after matching, since
subjects are determined to have been observed in an encouraging or unencouraging
facility by comparing instrument values within pairs. Despite this caveat, suitable
counterfactuals can be obtained in the following way.
Consider patients treated at facilities with γi > 0 to be observed in the encour-
agement state, while those at facilities with γi ≤ 0 to be observed in the unencour-
agement state. For individuals in the encouragement state, we have Dij = Dij(1)
and Yij = Yij(1, Dij(1)) from Equations (3.4) and (3.5). For counterfactuals, sam-
ple a γ from the unencouragement group and denote it γ∗. Dij(0) is then obtained
using equation (3.4) with P (Dij = 1) = P (Dij(0) = 1) = logit
−1(γ∗i + αX1,i +
δX2,ij + νij) and Yij(0, Dij(0)) is obtained using equation (3.5) with P (Yij = 1) =
P (Yij(0, Dij(0))) = logit
−1(βDij(0)+αX1,i+δX2,ij+ij). Counterfactuals for patients
observed in the unencouragement state can be obtained similarly. After obtaining
Dij(1), Dij(0), Yij(1, Dij(1)), and Yij(0, Dij(0)), these are plugged into Equation
(3.2) for the true effect, λ.
3.4.2 Results
Instrument Strength
The present work is motivated by the desire to strengthen the instrument by in-
creasing the separation of encouragement within pairs. Table 3.1 shows that both
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WIVM and NFM were able to do so, increasing the standardized difference in en-
couragement by approximately 25% and 65%, respectively. All things being equal,
the stronger instrument is preferred. Looking at match quality in the next section,
however, we will see that all things are not equal.
Table 3.1: Separation of encouragement within pairs. Reported is the mean treatment usage at un-
encouraging facilities (Z¯U ), encouraging facilities (Z¯E), and the standardized difference
between them, calculated as St Diff = 100(Z¯E − Z¯U )/
√
.5(s2ZE + s
2
ZU
), where s2ZE and
s2ZU are sample variances of mean treatment usage in each group. Results are based on
1,000 simulations.
(Z¯U , Z¯E) St Diff
IVM (37%, 62%) 141
WIVM (35%, 65%) 175
NFM (30%, 70%) 232
Match Quality
Table 3.2 reports balance of covariates X1 and X2 as indicated by the standardized
difference within pairs. The WIVM procedure produced consistently better covariate
balance than the NFM procedure. The particularly poor balance of facility level X1
under the NFM procedure shows that introducing penalties to the match negatively
impacted the ability to properly match on X1 in the first round.
Table 3.2: Covariate balance as reported by the standardized differences in covariates X1 and X2
within pairs. Results based on 1,000 simulations.
α δ IVM WIVM NFM
X1 0 0 0.01 0.01 0.34
0.25 0.25 0.15 0.14 18.01
0.50 0.50 0.14 0.16 36.10
X2 0 0 0.01 0.02 0.10
0.25 0.25 0.58 0.68 1.02
0.50 0.50 1.35 1.57 2.10
The pattern seen in Tables 3.1 and 3.2 shows a tradeoff of instrument strength
and match quality between WIVM and NFM. WIVM allows the matching algorithm
to focus entirely on matching on covariates, and strengthens the instrument through
weighting after the matches have been formed. NFM, on the other hand, incorpo-
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rates penalties into the match to enforce separation of the instrument, requiring the
matching algorithm to share priority between matching on covariates and strengthen-
ing the instrument. A large penalty might dominate the distance used for matching
and diminish the ability to properly match on covariates. In the tradeoff between
instrument strength and match quality, WIVM is willing to trade less instrument
strength for higher quality matches, while NFM is willing to trade lower quality
matches for a stronger instrument.
Estimation and Coverage
Table 3.3 presents estimation and coverage results under increasing magnitudes
of observed confounding. When α and δ are zero and matching on X1 and X2 is
trivial, each method is nearly unbiased and maintains nominal coverage. WIVM and
NFM achieved lower mean squared error than IVM, which is one benefit associated
with stronger instruments (Wooldridge, 2001). As α and δ increase and matching on
X1 and X2 becomes more important, the performance of IVM and WIVM remain
mostly unchanged. NFM, on the other hand, sees a large increase in bias and mean
squared errors and low coverage rates. The deterioration of performance for NFM
as α and δ increase can be attributed to its inability to properly match on X1.
Table 3.3: Bias, mean squared error (MSE), and 95% coverage probabilities (CP) for estimation of
λ. Bias and MSE are multiplied by 1,000. Coverage probabilities are based on confidence
intervals obtained using the permutation inference procedure Section 3.3 and Baiocchi
et al. (2010). Results are based on 1,000 simulations.
IVM WIVM NFM
α δ β λ Bias MSE CP Bias MSE CP Bias MSE CP
0 0 0.0 0.0 4.6 2.3 94.3 4.5 1.6 93.9 2.5 1.7 94.2
0.6 0.14 1.4 2.0 94.3 1.3 1.4 95.1 0.3 1.4 95.6
1.0 0.23 4.6 1.9 94.6 3.7 1.4 95.2 2.5 1.4 95.0
0.25 0.25 0.0 0.0 3.0 2.1 94.8 4.9 1.5 94.6 29.2 2.5 84.9
0.6 0.14 4.9 1.9 95.2 4.9 1.5 95.2 25.8 2.3 87.6
1.0 0.23 4.4 1.8 95.0 4.7 1.3 96.0 26.4 2.2 86.5
0.50 0.50 0.0 0.0 8.7 2.4 93.6 9.7 1.7 94.2 93.9 10.5 28.3
0.6 0.14 8.7 2.3 94.3 7.9 1.7 93.6 88.6 9.7 30.9
1.0 0.23 4.0 2.0 93.7 3.7 1.5 93.8 78.6 7.8 38.3
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3.5 Data Example
In this section we illustrate the use of IV-matching (IVM), weighted IV-matching
(WIVM), and near-far matching (NFM) with a study comparing mortality in the
first six months between patients receiving hemodialysis (HD) or peritoneal dialysis
(PD) as treatment for end stage renal disease. Complete information on 164,195
adults initiating dialysis for the first time between January 1, 2010 and December
31, 2013 was obtained from the United States Renal Data System. The analysis was
restricted to patients being treated at dialysis facilities with at least ten patients
that used both HD and PD during the study period. The analysis was conducted as
intention-to-treat, with treatment defined as the modality prescribed at the onset of
dialysis.
The instrument, facility mean PD usage, was calculated using data from 2007-2009
to avoid correlation with patient level confounders in the 2010-2013 period that was
used for the analysis. The instrument varied greatly across facilities, ranging from 0
to 100% with a mean of 9.8%. The correlation coefficient between a facilities 2007-
2009 and 2010-2013 PD usage was 0.68, indicating that facility preferences toward
PD are relatively stable through time, and that a facilities 2007-2009 PD usage is a
useful predictor of their 2010-2013 usage.
Figure 3.1 and Table B.1 of Appendix B confirm the belief that patients treated
with PD are generally healthier than those treated with HD. On average, they are six
years younger, receive more pre-ESRD care, suffer from less comorbidities, and are
more likely to be employed than HD patients. Additionally, facilities with higher PD
usage tend to be larger, as indicated by the higher number of nurses, social workers,
and hemodialysis stations. Since these factors could be related to unmeasured con-
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founders that affect patient outcomes, it is important to control for these variables
when matching.
We follow the two round matching procedure described in Section 3.2 for con-
structing matches. An optimal non-bipartite match first pairs facilities based on
facility level covariates. The facility in each pair with the greater mean PD usage is
considered to be an encouraging facility, while the other is considered unencouraging.
Within each of these pairs, an optimal bipartite match then pairs patients from the
encouraging facility with patients in the unencouraging facility.
For the first round facility level match, we defined the distance between facilities
using a Mahalanobis distance based on the facility covariates in Figure 3.1 and Tables
B.1 or B.2 of Appendix B. For the NFM procedure, a penalty was added to this
distance if facilities instrument values were within 14% of each other (the inter-
quartile range), and 50% of facilities were allowed to pair with sinks and be removed
from the analysis. For the second round patient level match, we matched on a
prognostic score based on the patient level covariates in Figure 3.1 and Tables B.1
or B.2 of Appendix B. For the WIVM procedure, a weight was assigned to each pair
based on Equation (3.1), where probabilities were estimated using the instrument,
facility mean PD usage from 2007-2009.
Of the 164,195 patients, 128,700 were paired using the IVM and WIVM procedure,
while 67,904 were paired using the NFM procedure. The average unencouraged and
encouraged patient was treated at a facility with PD usage from 2007-2009 of 4.7%
and 15.3% using the IVM procedure, 6.3% and 27.8% using the WIVM procedure,
and 3.8% and 25.3% using the NFM procedure. For WIVM and NFM, the increased
separation corresponds with roughly a 100% increase in the standardized difference
in encouragement, with neither procedure performing notably better than the other
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in terms of instrument strength.
Covariate balance after matching is presented in Figure 3.1 as well as Table B.2
of Appendix B. Covariate balance is improved compared with pre-matching under
each of the three methods. IVM and WIVM, however, generally resulted in better
balance than NFM, particularly for facility level covariates where NFM seems to
struggle. These results are similar to those seen in the simulations of Section 3.4.
Figure 3.1: Covariate balance before and after matching as indicated by the standardized differences
within pairs. Dashed grey lines are at ±10. Standardized differences larger than this
have been suggested to represent an imbalance (Normand et al., 2001).
Estimation results reported in Table 3.4 indicate that PD has a protective effect
on mortality in the first six months. For example, λˆ = −0.09 suggests that for every
100 subjects that are encouraged to switch from HD to PD, there are nine fewer
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Table 3.4: Estimate and 95% confidence interval for the local average treatment effect. Estimated
effect represents the expected decrease in death for patients that could be encouraged
to switch from hemodialysis to peritoneal dialysis.
λˆ 95% CI
IVM -0.09 (-0.14, 0.03)
WIVM -0.09 (-0.15, -0.06)
NFM -0.07 (-0.10, -0.04)
deaths in the first six months. Both WIVM and NFM decreased the width of the
confidence interval associated with λ compared to IVM, with NFM leading to the
narrowest interval.
3.6 Discussion
Weak instrumental variables present many problems to an IV analysis, including
greater finite-sample bias and greater variability in estimation. Results obtained
using weak instruments have also been shown to be less robust to unmeasured
instrument-outcome confounders that violate the assumption that the instrument
is randomly assigned (Bound et al., 1995; Small and Rosenbaum, 2008). These bene-
fits have motivated recent methods for strengthening the instrument (Baiocchi et al.,
2010, 2012).
In this chapter, we proposed a weighting procedure for building a stronger in-
strument in the IV-matching framework (Baiocchi et al., 2010, 2012). The key idea
is that the data can be redistributed through weighting to highlight pairs in a way
that increases the strength of the instrument. The proposed weights were based on
the probability that a pair complies with encouragement, or that the encouraged
subject in a pair receives the treatment while the unencouraged subject receives the
control. Other weights could be considered as long as more weight is assigned to
pairs that are more influenced by the instrument. In future work we are considering
the possibility of an “optimal” weight, perhaps subject to a constraint on covariate
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balance.
Compared with existing methods for strengthening the instrument, weighting is
able to strengthen the instrument without compromising match quality. This is
because weights are applied after matches have been formed, as opposed to meth-
ods that strengthen the instrument simultaneously with matching. This is a major
strength of the proposed method since failing to properly match on important co-
variates can bias estimation.
Using data from the United States Renal Data System, methods were illustrated
in a study comparing mortality in the first six months between patients receiving
hemodialysis or peritoneal dialysis as treatment for end state renal disease. The pro-
posed weighting procedure was able to strengthen the instrument while maintaining
good match quality. A protective effect of peritoneal dialysis was found, suggesting
that we expect nine fewer deaths for every 100 patients that could be encouraged to
switch from hemodialysis to peritoneal dialysis.
The methods discussed in this chapter have been motivated by the desire to
achieve the benefits associated with stronger instruments. These include decreased
finite-sample bias, greater efficiency, and improved robustness to violations of the
assumption that the instrument is randomly assigned. It has yet to be shown, how-
ever, that a strengthened instrument can provide the same benefits as an instrument
that naturally has high correlation with the treatment. We undertake this task in
the next chapter, where we investigate the performance of strengthened instrumental
variables to better understand their properties.
CHAPTER IV
Properties of Strengthened Instrumental Variables
4.1 Motivation
In the previous chapter we discussed methods for increasing the strength of an in-
strumental variable. Methods for strengthening the instrument have been motivated
by the desire to capitalize on the advantages of using stronger instruments. These
advantages include decreased finite-sample bias and greater efficiency in estimation
(Bound et al., 1995; Angrist et al., 1996; Wooldridge, 2001). Additionally, results
obtained using stronger instruments are more robust to violations of the assumption
that the instrument is randomly assigned (Small and Rosenbaum, 2008; Baiocchi
et al., 2010). It has yet to be shown, however, that strengthened instruments pro-
vide the same benefits as instruments that are naturally stronger. We use the term
“strengthened” to refer to an instrument whose correlation with the treatment has
been increased by the researcher and the term “naturally stronger” to refer to an in-
strument that is more highly correlated with the treatment without any effort made
by the researcher to increase this correlation. The focus of this chapter is to study
estimation with strengthened instruments to better understand their properties and
how they compare with instruments that are naturally stronger.
To illustrate the benefits of using stronger instruments, suppose that we wish to
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estimate β in the linear model
(4.1) Y = β0 + βD + .
If any unmeasured confounders exist between the treatment D and outcome Y they
will go into the error term, . This induces correlation between the treatment and
the error term, which then biases estimates of β when (4.1) is modeled directly. This
bias arising from unmeasured treatment-outcome confounding is the problem an IV
analysis hopes to overcome.
Now assume that we have an instrument, Z, that is related to the treatment as
(4.2) D = ψ0 + ψ1Z + ν,
where ψ1 6= 0 by assumption. Given a random sample {(Di, Yi, Zi) : i = 1, 2, ..., n},
the IV estimator of β is defined as
(4.3) βˆIV =
(
n−1
n∑
i=1
ZiDi
)−1(
n−1
n∑
i=1
ZiYi
)
.
From Bound et al. (1995) or Wooldridge (2001), the probability limit of this estimator
can be written as
(4.4) plim(βˆIV ) = β +
Corr(Z, )
Corr(Z,D)
σ
σD
,
where σ and σD are the standard deviations of the error and the treatment, respec-
tively. Equation (4.4) shows that correlation between the instrument Z and error
term  biases the IV estimate of β.
An important insight from (4.4) is that stronger instruments, or those that have
greater correlation with the treatment, lessen the damage to estimation caused by
correlation between Z and . Correlation between Z and  can arise in two ways.
It can be a finite-sample issue, since correlation is never exactly zero in any finite-
sample. It can also result from unmeasured instrument-outcome confounders. Just
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as unmeasured treatment-outcome confounders induce correlation between D and 
that biases estimates of β when (4.1) is modeled directly, unmeasured instrument-
outcome confounders induce correlation between Z and  that biases IV estimates of
β. Stronger instruments therefore decrease finite-sample bias and increase robustness
unmeasured instrument-outcome confounders that violate the assumption that the
instrument is randomly assigned (Bound et al., 1995; Angrist et al., 1996).
The improved robustness to unmeasured instrument-outcome confounders is es-
pecially important. Finite-sample bias deceases toward zero as sample size increases
and is often not a major issue in observational studies. Bias arising from unmeasured
instrument-outcome confounders, however, cannot be eliminated through increasing
sample sizes (Small and Rosenbaum, 2008). Additionally, we cannot guarantee that
unmeasured instrument-outcome confounders do not exist and the assumption may
face criticism. Stronger instruments are therefore one way to increase the credibility
of the results of an IV analysis.
Recent methods have been proposed for strengthening the instrument in IV-
matching designs (Baiocchi et al., 2010, 2012). It has been taken for granted, how-
ever, that strengthened instruments provide the same benefits as instruments that
are naturally stronger. In this chapter, we study estimation with strengthened in-
struments to determine their properties and how they compare with instruments
that are naturally stronger. The remainder of this chapter is organized as follows.
In Section 4.2 we introduce matching in IV analyses and discuss two recently pro-
posed methods for strengthening the instrument in IV-matching designs. Inference
is discussed in Section 4.3, along with a sensitivity analysis for assessing sensitiv-
ity to unmeasured instrument-outcome confounders. We study the performance of
strengthened instruments through simulations in Section 4.4, and conclude with a
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discussion in Section 4.5.
4.2 Methods
Throughout this section, we will assume that we measure covariates X, binary
treatment D, and response Y for each of n individuals. We further assume that we
measure a continuous instrument that can be dichotomized to indicate “enourage-
ment” toward the treatment. The term encouragement is used to mean that indi-
viduals with instrument Z = 1 are more likely to receive treatment than individuals
with Z = 0, and not necessarily that individuals received actual or physical encour-
agement.
Matching in an IV analysis with a binary instrument aims to pair individuals that
have been encouraged toward the treatment with individuals that look similar on rel-
evant covariates, but have been encouraged toward the control. After matching, the
match quality can be assessed through covariate balance (Love, 2002; Austin, 2009a)
and instrument strength can be assessed by the average difference, or separation,
of the instrument within pairs (Baiocchi et al., 2010, 2012). Stronger instruments
are associated with greater separation of the instrument. We therefore hope to pair
individuals that are similar on relevant covariates but received a large difference in
encouragement toward the treatment.
In the following sections we present three strategies for matching in an IV analysis:
a standard matching procedure which we refer to as IV-matching, the weighted IV-
matching procedure of Chapter III, and the near-far matching procedure of Baiocchi
et al. (2010, 2012). IV-matching involves matching on covariates X, but takes the
strength of the instrument as given and does not strengthen it. The other two pro-
cedures match on covariates X and increase the separation of the instrument within
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pairs, thereby strengthening the instrument. Weighted IV-matching increases sepa-
ration by assigning more weight to pairs that are more influenced by the instrument,
while near-far matching increases separation by discouraging individuals with similar
instrument values from ever pairing.
4.2.1 IV-Matching
IV-matching begins by defining a distance between each individual based on co-
variates X. An optimal nonbipartite match (Derigs, 1988; Lu et al., 2011) then pairs
individuals such that the sum of these distances over all pairs is minimized. After
matching, the instrument is dichotomized into encouragement by comparing instru-
ment values within each pair, and considering the individual in each pair with the
higher instrument value to have been encouraged toward treatment. Let i denote
pair and let j and j′ denote subjects within pair i. Assign Zij = 1 and Zij′ = 0 if
subject j in pair i had a higher instrument value than subject j′ 6= j. Assign Zij = 0
and Zij′ = 1 otherwise. Note that Zij + Zij′ = 1 for all i, so that each pair has one
encouraged and one unencouraged subject.
4.2.2 Weighted IV-Matching
Weighted IV-matching follows the same steps as IV-matching for constructing
pairs based on covariates X and assigning encouragement. To strengthen the instru-
ment, a weight is assigned to each pair after matching based on the influence of the
instrument within that pair. In Chapter III, we proposed weighting pair i by
(4.5) wi = P (Dij = 1|Zij = 1)P (Dij′ = 0|Zij′ = 0),
which is designed to reflect the probability that the encouraged subject receives the
treatment while the unencouraged subject receives the control. This is a measure
of the instrument’s influence over the treatment within pair i, and a strengthened
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instrument is created when more weight is assigned to pairs in which the instru-
ment has more influence over the treatment. This strategy for strengthening the
instrument effectively redistributes the data through weights to highlight portions
associated with greater instrument strength. This weight, as well as the weighted
IV-matching procedure, is discussed throughout Chapter III.
4.2.3 Near-far Matching
The near-far matching procedure of Baiocchi et al. (2010, 2012) strengthens the
instrument with a modification to the matching phase of the IV-matching process.
When defining the distance between individuals based on covariates X, a penalty is
added to the distance between individuals whose instrument values are within a pre-
specified range of each other. This penalty discourages the matching algorithm from
pairing those individuals. As a result, pairs are more likely to consist of individuals
with instrument values suitably far apart. In addition to these penalties, sinks are
added to the match to allow a pre-specified number of individuals to be optimally
removed from the analysis (Lu et al., 2001). This alleviates some of the damage
to match quality caused by adding penalties to the distances used for matching.
The instrument is again dichotomized into encouragement by comparing instrument
values within each pair, and considering the individual in each pair with the higher
instrument value to have been encouraged toward treatment.
After implementing one of these three matching procedures, we have I pairs that
were matched on covariates X. One subject in each pair is considered to have been
encouraged toward the treatment and the other toward the control. In the next
section, we discuss estimating an effect of treatment. We also present a sensitivity
analysis for assessing robustness to unmeasured instrument-outcome confounders
that violate the assumption that the instrument is randomly assigned.
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4.3 Inference
4.3.1 Estimation
We implement the estimation and inference procedures of Section 3.2 for estimat-
ing the local average treatment effect, defined here as
(4.6) βIV =
∑
i
∑
j (Yij(1, Dij(1))− Yij(0, Dij(0)))∑
i
∑
j (Dij(1)−Dij(0))
,
where Yij(1, Dij(1)) and Yij(0, Dij(0)) denote the potential responses for subject j
in pair i and Dij(1) and Dij(0) denote the potential treatments. Under assumptions
A1-A5 of Section 2.2, this parameter is interpreted as an average treatment effect
among the subgroup of the population known as compliers (Table 2.1). Compliers
are individuals that can be encouraged to switch treatment states and are often
referred to as “marginal patients.” More discussion of this parameter can be found
in Chapter II, as well as Imbens and Angrist (1994), Angrist et al. (1996), or Baiocchi
et al. (2014).
Let Yij = ZijYij(1, Dij(1)) + (1− Zij)Yij(0, Dij(0)) be the observed response and
Dij = ZijDij(1) + (1−Zij)Dij(0) the observed treatment for subject j in pair i. We
estimate βIV after matching as
(4.7) βˆIV =
∑I
i=1 wˆi
∑2
j=1 [ZijYij − (1− Zij)Yij]∑I
i=1 wˆi
∑2
j=1 [ZijDij − (1− Zij)Dij]
,
where wˆi = 1 for the IV-matching and near-far matching procedures. We follow the
permutation inference procedure of Baiocchi et al. (2010), outlined in Section 3.2,
for obtaining confidence intervals for βˆIV .
4.3.2 Sensitivity Analysis
The improved robustness to violations of the assumption that the instrument
is randomly assigned is a key benefit of working with stronger instruments and has
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been the primary motivation behind methods for strengthening the instrument. Ran-
dom assignment of the instrument implies that there are no unmeasured instrument-
outcome confounders. Unfortunately, this assertion cannot be verified and is often
criticized. Being robust to unmeasured instrument-outcome confounders can there-
fore increase the credibility of the results from an IV analysis.
In this section we discuss a sensitivity analysis that provides guidance as to how
robust estimates are to violations of this assumption. This sensitivity analysis is out-
lined in Rosenbaum (2002) and applied in instrumental variable settings in Baiocchi
et al. (2010, 2012). The goal of this analysis is to determine how far an instrument
can deviate from being randomly assigned before the qualitative results of the study
are altered. We can think of this as determining how large or how strong an unmea-
sured instrument-outcome confounder would need to be to explain what appears to
be a significant treatment effect.
Following Rosenbaum (2002), we assume that within pair i matched on covariates
X, subjects j and j
′
differ in their odds of receiving encouragement by at most a
factor of Γ ≥ 1, where
1
Γ
≤ piij(1− piij′)
piij′(1− piij) ≤ Γ for all i, j, j
′ with Xij = Xij′(4.8)
and piij = P (Zij = 1|Xij). When the instrument is randomly assigned and each
subject has equal odds of receiving encouragement, piij = piij′ and Γ = 1. As random
assignment of the instrument is increasingly violated, these probabilities diverge and
Γ increases.
The sensitivity analysis is conducted by using Γ in inference procedures to obtain
bounds on the p-value associated with testing the hypothesis that βIV = 0. For
matched pairs with a continuous response, we can do this using Wilcoxon’s signed
rank test for testing the association between encouragement and the outcome (Small
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and Rosenbaum, 2008). This involves taking the difference in response values be-
tween encouraged and unencouraged subjects for each of the I pairs, ranking these
differences, and summing the ranks for pairs in which the encouraged subject had
the higher response value. This sum is then compared to two normal distributions
with expectation pI(I + 1)/2 and variance p(1 − p)I(I + 1)(2I + 1)/6 to obtain p-
values, where p = 1/(1 + Γ) is used for obtaining a lower bound and p = Γ/(1 + Γ)
is used for an upper bound. This is repeated for increasing values of Γ. The largest
deviation from random assignment that can be sustained is given by the largest Γ
value in which the upper bound for the p-value remains less than 0.05, with larger
deviations indicating results that would require a larger unmeasured instrument-
outcome confounder to explain them. Notice that when Γ = 1 the expectation and
variance reduce to the usual expectation and variance for Wilcoxon’s signed-rank
test (Lehmann, 1975). For applications of this sensitivity analysis with other test
statistics, see Rosenbaum (2002), Baiocchi et al. (2010, 2012).
The parameter Γ has the advantage of being a univariate measure for quantifying
a deviation from random assignment, but its magnitude is not easily interpreted in
the context of the problem. To help with interpretations, Rosenbaum and Silber
(2009) present a mapping of Γ to two components as
(4.9) Γ =
∆Λ + 1
∆ + Λ
,
where ∆ represents the effect of an unmeasured confounder on the instrument and
Λ the effect of that unmeasured confounder on the response. For example, an un-
measured confounder that triples the odds of receiving encouragement (∆ = 3) while
doubling the odds of having the higher response value (Λ = 2) corresponds with a Γ
value of (3 · 2 + 1)/(3 + 2) = 1.4. This mapping of Γ allows the sensitivity analysis
to remain relatively simple while allowing the researcher to better understand and
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interpret the results in a meaningful way and in the context of the problem.
4.4 Simulations
4.4.1 Setup
In this section we report simulation results to study the properties of strengthened
instruments. We compare estimation under four matching procedures. Two involve
pairing individuals using the IV-matching procedure of Section 4.2.1, matching on
covariates without strengthening the instrument. One of these matches will use a
relatively weak instrument (IVM-I) while the other will use an instrument that is
naturally stronger (IVM-II), allowing for comparisons when all else is equal except
the strength of the instrument. The remaining two matches will use the relatively
weak instrument but strengthen it, one using the weighted IV-matching (WIVM)
procedure described in Section 4.2.2 and one using the near-far matching (NFM)
procedure described in Section 4.2.3. We refer to these four matches as using weaker
(IVM-I), stronger (IVM-II), and strengthened (WIVM, NFM) instruments.
We generate 1,000 datasets from
Yi = βDi +Xi + 
Y
i + αUi,(4.10)
logit(P (Di = 1)) = Z1i + Z2i + 
D
i ,(4.11)
Z1i = γ1i + αUi,(4.12)
Z2i = γ2i,(4.13)
where Y represents the response and D the treatment for each of i = 1, ..., 4, 000
individuals. Covariate X and random effects γ1 and γ2 are randomly generated from
standard normal distributions. Errors (Y , D) are generated from a bivariate nor-
mal with correlation 0.75 to represent unmeasured treatment-outcome confounding.
Unmeasured instrument-outcome confounder U is generated from a Bernoulli distri-
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bution with probability 0.5. The parameter α is used to control the strength of U
and is varied from 0 to 1. When α > 0, the presence of U in the generating equations
for Y and Z violates the assumption that the instrument is randomly assigned. We
estimate the effect of the treatment on the response, β, which we set to 0 throughout
these simulations.
To represent the weaker instrument for IVM-I, the instrument is defined as Zi =
Z1i = γ1i + αUi. For IVM-II, the stronger instrument is defined as Zi = Z1i + Z2i =
γ1i + γ2i + αUi. These two instruments capture approximately 10% and 22% of
the variation in the treatment, respectively, while holding everything else constant.
WIVM and NFM will use the weaker instrument but strengthen it via the meth-
ods described in Sections 4.2.2 and 4.2.3. This setup allows for a comparison of
weaker instruments (IVM-I) with instruments that are naturally stronger (IVM-II)
and instruments that have been strengthened by the researcher (WIVM, NFM).
4.4.2 Results
Instrument Strength
Figure 4.1 reports instrument strength as indicated by separation of the in-
strument. Greater separation is considered to correspond with greater instrument
strength. Results confirm that IVM-II, WIVM, and NFM are using a stronger in-
strument than IVM-I as expected. Both WIVM and NFM were able to strengthen
the weak instrument, with NFM achieving separation of the instrument roughly
equivalent to that of IVM-II. Separation of the instrument increases slightly as un-
measured instrument-outcome confounding increases, a result of the the instrument
taking more extreme values as α increases.
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Figure 4.1: Separation of the instrument for each method by magnitude of unmeasured instrument-
outcome confounding. Displayed is the average difference in instrument values between
encouraged and unencouraged individuals. Greater differences are considered to corre-
spond with greater instrument strength.
Estimation
Figure 4.2 reports estimates of β (top), the width of 95% confidence intervals
(middle), and 95% coverage probabilities (bottom) for each method. Since β is set
to 0, estimates of β can also be considered the bias in estimation. Note that the lines
for IVM-I, WIVM, and NFM are overlapping in the plot of the estimates. We see that
as the level of unmeasured instrument-outcome confounding increases, as measured
by α, the bias increases as well for each method. The bias for IVM-II is decreased
compared with the bias for IVM-I at every level of α > 0. WIVM and NFM, on the
other hand, are equally biased compared with IVM-I. The decreased bias for IVM-II
allows it to maintain higher 95% coverage probability than either of the remaining
three methods, though each method has coverage decreasing to 0% as unmeasured
instrument-outcome confounding increases. The plot of confidence interval widths
shows that IVM-II, WIVM, and NFM were more efficient than IVM-I, with IVM-II
leading to the narrowest intervals of the four methods.
These results reveal an important difference between strengthened (WIVM, NFM)
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Figure 4.2: Estimation of β, width of confidence intervals, and 95% coverage probabilities under an
increasing magnitude (α) of unmeasured instrument-outcome confounding. Note that
the lines for IVM-I, WIVM, and NFM are overlapping in the top plot.
and naturally stronger instruments (IVM-II). Theoretical results suggest that greater
correlation between the instrument and the treatment decreases the bias arising from
unmeasured instrument-outcome confounding and increases efficiency in estimation.
IVM-II had both of these properties while using the naturally stronger instrument.
WIVM and NFM, however, provided for more efficient estimation but failed to de-
crease the bias caused by unmeasured instrument-outcome confounder U .
We investigate this issue further by estimating the ratio of the correlation between
the instrument and unmeasured instrument-outcome confounder U to the correlation
between the instrument and the treatment. This ratio is displayed by α in Figure
4.3. Notice that the lines for IVM-I, WIVM, and NFM are again overlapping, while
that for IVM-II is decreased. The overlapping of WIVM and NFM with IVM-I indi-
cates that although WIVM and NFM were able to increase the correlation between
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the instrument and the treatment, the correlation between the instrument and the
unmeasured instrument-outcome confounder U was increased proportionally. This
proportional increase in the correlation between the instrument and U explains why
WIVM and NFM did not see a decrease in bias in Figure 4.2 like IVM-II did.
Figure 4.3: Ratio of the correlation between the instrument and unmeasured instrument-outcome
confounder U to the correlation between the instrument and the treatment. Note that
lines for IVM-I, WIVM, and NFM are overlapping.
The increase in the strength of unmeasured instrument-outcome confounding re-
sulting from methods that strengthen the instrument has thus far been overlooked
in the literature. When doing so, results from the sensitivity analysis presented in
the following section can be misinterpreted to suggest improved robustness to un-
measured instrument-outcome confounding when, as Figures 4.2 and 4.3 make clear,
there is no improvement. We believe this to be why strengthened instruments have
previously been suggested to be more robust to unmeasured instrument-outcome
confounders.
Sensitivity
Figure 4.4 displays the results of the sensitivity analysis of Section 4.3.2. The
vertical axis, Γ, measures the deviation from random assignment that our estimates
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are considered robust to. Γ can be related to the size of an unmeasured instrument-
outcome confounder as in (4.9), telling us how large one would need to be to explain
what appears to be a significant effect of the treatment.
Results suggest that estimates obtained using WIVM and NFM would require a
larger unmeasured instrument-outcome confounder to explain them compared with
IVM-I, while estimates obtained using IVM-II would require a smaller one. These
results need to be interpreted with caution. Applications of this sensitivity anal-
ysis typically consider larger values of Γ to correspond with more robust results
(Rosenbaum, 2002; Small and Rosenbaum, 2008; Baiocchi et al., 2010, 2012), but we
see here that this is not always true. This sensitivity analysis tells us how strong
an unmeasured instrument-outcome confounder would need to be to explain a sig-
nificant effect. This is often used interchangeably with robustness to unmeasured
confounders but it is quite different. Consider, for example, the sensitivity results
for WIVM and NFM. Both methods found larger Γ values in the sensitivity analysis,
suggesting that estimates obtained using WIVM and NFM would require a stronger
unmeasured instrument-outcome confounder to explain them compared to estimates
obtained using IVM-I or IVM-II. While this sounds like improved robustness, results
in Figure 4.3 showed that WIVM and NFM actually increased the strength of un-
measured instrument-outcome confounder U , and results in Figure 4.2 showed that
results were no less biased in the presence of U . If the increase in the strength of U
caused by the WIVM and NFM procedures is ignored, Γ can easily be misinterpreted
to suggest improved robustness when there is none.
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Figure 4.4: Results of sensitivity analysis for assessing robustness to unmeasured instrument-
outcome confounding as measured by Γ. A larger Γ indicates that a larger unmea-
sured instrument-outcome confounder would be required to explain a significant effect
estimate.
4.5 Discussion
Instrumental variable methods are increasingly used in health and medical re-
search. Unfortunately, instrumental variable analyses rely on assumptions that are
difficult to verify and often criticized. One way to increase the credibility of the
results of an instrumental variable analysis is to work with stronger instruments, or
instruments that are highly correlated with the treatment. Benefits of using stronger
instruments include a decrease in finite-sample bias, increased efficiency in estima-
tion, and improved robustness to unmeasured instrument-outcome confounders that
violate the assumption that the instrument is randomly assigned. Motivated by the
desire to capitalize on these benefits, recent methods have been proposed to increase
the strength of a weak instrumental variable. It has been taken for granted, however,
that a weak instrument that has been strengthened provides these same benefits.
In this chapter, we investigated estimation with strengthened instruments to bet-
ter understand their properties and how they compare with instruments that are
naturally stronger. Our findings revealed important differences between the two.
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Specifically, we found that while strengthened instruments are able to increase ef-
ficiency in estimation, they do not lead to a decrease in finite-sample bias or im-
prove the robustness to unmeasured instrument-outcome confounders. We found
that methods for strengthening the instrument additionally strengthen the relation-
ship between the instrument and any unmeasured instrument-outcome confounders,
which offsets any potential decrease in bias or improved robustness.
The increase in the strength of unmeasured instrument-outcome confounding that
results from methods that strengthen the instrument is an important finding that
has been overlooked in the literature thus far. Ignoring this issue leads to mis-
leading sensitivity results, and is likely why strengthened instruments have been
suggested to improve robustness to unmeasured instrument-outcome confounders in
the same way that naturally stronger instruments do. This is a major shortcoming
of strengthened instruments, since improved robustness to unmeasured instrument-
outcome confounding is arguably the most important benefit of working with stronger
instruments. These findings suggests that strengthened instruments should not be
considered equal to instruments that are naturally stronger.
Results of this work can give guidance for future research related to strength-
ening instrumental variables. One important takeaway from these findings is that
improving robustness to unmeasured instrument-outcome confounders via strength-
ening the instrument will require the development of methods that do not increase
the strength of unmeasured instrument-outcome confounding in the process. These
findings highlight that strengthened instruments appear most useful for decreasing
the variability in estimation. If future research on strengthening the instrument is
framed in the context of decreasing variability rather than improving robustness to
unmeasured instrument-outcome confounding, this may pave the way for the devel-
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opment of more efficient IV methods.
CHAPTER V
Conclusion
In observational studies, unmeasured differences between treatment groups often
confound the relationship of interest. Instrumental variable (IV) methods can give
consistent effect estimates in the presence of this unmeasured confounding, and are
becoming increasingly popular in health and medical research. This dissertation
has focused on the development of new IV methods, with applications to studies
comparing mortality among patients receiving dialysis as treatment for end stage
renald disease.
In Chapter II, we developed a weighted IV estimator that adjusts for measured
instrument-outcome confounders through the IV propensity score. The weights were
designed to reflect the probability of being selected into a one-to-one match. Advan-
tages of weighting over matching include increased efficiency, straightforward vari-
ance estimation, and ease of computation. Through simulation, the estimator was
shown to be more efficient than both matching and alternative weighted estimators.
Use of the estimator was illustrated in a study comparing the relationship between
mortality and dialysis session length among hemodialysis patients. Future work re-
lated to applying this estimator to time-to-event or survival data was also presented.
In Chapter III, we developed a weighting procedure for increasing the strength of
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the instrument when matching. Compared with existing methods, this weighting pro-
cedure strengthened the instrument without compromising match quality. This is a
major advantage of the proposed method, as poor match quality can bias estimation.
Methods were illustrated with a study comparing early mortality in hemodialysis and
peritoneal dialysis patients.
In Chapter IV, we compared estimation with strengthened instruments to esti-
mation with instruments that are naturally stronger. Methods for strengthening the
instrument have been motivated by the benefits of using stronger instruments, in-
cluding decreased finite-sample bias, increased efficiency, and results that are more
robust to unmeasured instrument-outcome confounders. We found that strengthened
instruments were unable to provide these same benefits, as has been previously sug-
gested. Our findings indicated that while strengthened instruments provide for more
efficient estimation, they do not lead to a decrease in finite-sample bias or improve the
robustness to unmeasured instrument-outcome confounders. We found that methods
for strengthening the instrument inadvertently strengthen unmeasured instrument-
outcome confounders in the process. This important issue has thus far been over-
looked in the literature, which has led to the misbelief that strengthened instruments
improve robustness to unmeasured instrument-outcome confounders. These findings
give guidance for future research related to strengthening the instrument.
APPENDICES
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APPENDIX A
Asymptotic equivalence of IV-MW and IV-PSM estimators
In this section we show that the IV-MW and IV-PSM estimators have the same
limit as n → ∞. Following Li and Greene (2013), we will assume that the IV
propensity score takes finitely many values ck for k = 1, ..., K with ck ∈ (0, 1).
This assumption is to allow exact matching on the IV propensity score and avoid
unnecessary complications of working with other matching algorithms. For the IV-
PSM estimator we assume one-to-one exact matching without replacement on the
IV propensity score. Additionally, we simplify the notation of section 2.2, letting
Y (1, Di(1)) = Y
1
i , Yi(0, Di(0)) = Y
0
i , Di(1) = D
1
i , Di(0) = D
0
i , Yi = ZiY
1
i + (1 −
Zi)Y
0
i , Di = ZiD
1
i + (1−Zi)D0i , and ei(xi) = ei. We further denote P (ei = ck) = τk,
with
∑
k τk = 1.
We begin with the IV-MW estimator, defined as
λIV-MW =
∑
iWiZiYi/
∑
iWiZi −
∑
iWi(1− Zi)Yi/
∑
iWi(1− Zi)∑
iWiZiDi/
∑
iWiZi −
∑
iWi(1− Zi)Di/
∑
iWi(1− Zi)
≡ A/F −B/G
C/F −D/G.
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The limit for A is
n−1
∑
i
WiZiYi →p E{WiZiY 1i }
= E
{
E(
min(ei, 1− ei)
ei
I(Zi = 1)Y
1
i |xi)
}
= E{min(ei, 1− ei)E(Y 1i |xi)}.
Similarly, the limits for B, C, and D are given by
n−1
∑
i
Wi(1− Zi)Yi →p E{min(ei, 1− ei)E(Y 0i |xi)},
n−1
∑
i
WiZiDi →p E{min(ei, 1− ei)E(D1i |xi)},
n−1
∑
i
Wi(1− Zi)Di →p E{min(ei, 1− ei)E(D0i |xi)}.
Taking the limit of F and G gives
n−1
∑
i
WiZi →p E{WiZi}
= E
{
min(ei, 1− ei)
ei
I(Zi = 1)
}
= E{min(ei, 1− ei)}
and
n−1
∑
i
Wi(1− Zi) →p E{min(ei, 1− ei)}
Combining these and reducing, the limit of the IV-MW as n→∞ is given as
λˆIV-MW →p E{min(ei, 1− ei)(E(Y
1
i |xi)− E(Y 0i |xi))}
E{min(ei, 1− ei)(E(D1i |xi)− E(D0i |xi))}
.
Next we consider the IV-PSM estimator, which we write as
λˆIV-PSM =
{∑
k
∑
i YiI(i∈S1k)∑
k
∑
i I(i∈S1k)
}
−
{∑
k
∑
i YiI(i∈S0k)∑
k
∑
i I(i∈S0k)
}
{∑
k
∑
iDiI(i∈S1k)∑
k
∑
i I(i∈S1k)
}
−
{∑
k
∑
iDiI(i∈S0k)∑
k
∑
i I(i∈S0k)
} ≡ A/F −B/G
C/F −D/G,
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where S1k and S0k represent the sets of encouraged and unencouraged subjects
matched at ck, respectively. The limit of A is then
n−1
∑
k
∑
i
YiI(i ∈ S1k) = n−1
∑
k
∑
i
Y 1i I(i ∈ S1k)
→p E
{∑
k
Y 1i I(i ∈ S1k)
}
= E
{
E(Y 1i |xi)E(
∑
k
I(i ∈ S1k)|xi)
}
= E
{
E(Y 1i |xi)
∑
k
τkei
min(ei, 1− ei)
ei
}
= E{min(ei, 1− ei)E(Y 1i |xi)}.
Similarly, the limits for B, C, and D are given as
n−1
∑
k
∑
i
YiI(i ∈ S0k)→p E{min(ei, 1− ei)E(Y 0i |xi)},
n−1
∑
k
∑
i
DiI(i ∈ S1k)→p E{min(ei, 1− ei)E(D1i |xi)},
n−1
∑
k
∑
i
DiI(i ∈ S0k)→p E{min(ei, 1− ei)E(D0i |xi)}.
Finally, for F we have
n−1
∑
k
∑
i
I(i ∈ S1k) →p E
{∑
k
I(i ∈ S1k)
}
= E
{
min(ei, 1− ei)
∑
k
τk
}
= E{min(ei, 1− ei)},
and similarly for G
n−1
∑
k
∑
i
I(i ∈ S0k) →p E{min(ei, 1− ei)}.
Combining everything and reducing, the limit of the IV-PSM estimator as n→∞
is found to be
λˆIV-PSM →p= E{min(ei, 1− ei)(E(Y
1
i |xi)− E(Y 0i |xi))}
E{min(ei, 1− ei)(E(D1i |xi)− E(D0i |xi))}
,
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which is the same as that of the IV-MW estimator.
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APPENDIX B
Full list of covariates used in data example of Chapter III
Table B.1. Summary of covariates before matching. Patient level covariates are compared
across dialysis modality and facility level covariates are compared across first
and fourth quartile of the PD usage.
Patient Covariates HD PD St Diff
N 142,737 21,458 -
Outcome
Death w/in 6 months 14% 4% 35.7
Covariates
Age 64 58 37.7
Male 57% 55% 3.8
Bmi 29.6 29.5 1.9
6+ months pre-ESRD care 45% 69% -49.3
# of comorbidities 2.4 1.9 44.1
Hemoglobin 9.9 10.6 -4.2
Serum creatinine 6.6 6.4 1.0
No insurance 7% 8% -6.9
White 68% 71% -5.1
Black 26% 22% 8.7
Asian 4% 5% -7.4
Hispanic 13% 12% 2.2
Employed 9% 26% -45.2
Facility Covariates Q 1 Q 4 St Diff
Instrument
PD usage 3% 30% -208
Covariates
For profit 85% 86% -3.3
# of nurses 6.7 8.7 -43.3
# of technicians 8.2 8.1 2.0
# of social workers 0.8 1.1 -36.4
# of HD stations 20.3 21.9 -19.1
Median income $51,086 $50,850 1.2
Bachelors degree + 23.7% 23.4% 4.5
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Table B.2. Summary of covariates after matching, by matching algorithm. U and E correspond to patients
considered to have been treated at PD unencouraging (U) and PD encouraging (E) facilities.
IVM (64,350 pairs) WIVM (64,350 pairs) NFM (33,702 pairs)
U E St Diff U E St Diff U E St Diff
Instrument
Facility % PD 2007-09 4.7% 15.3% -96.3 6.3% 27.8% -194.8 3.8% 25.3% -195.2
Treatment
PD 10.0% 16.3% -18.7 11.5% 23.5% -35.7 9.0% 23.8% -44.1
Outcome
Died w/in 6 months 11.9% 11.3% 1.7 11.7% 10.7% 3.3 11.8% 10.8% 3.1
Patient Covariates
Age 62.8 62.7 0.5 62.6 62.1 3.5 63.0 62.2 5.0
Male 57.0% 56.9% 0.2 57.3% 56.7% 1.3 57.0% 56.7% 0.6
BMI 30.5 30.4 0.5 30.5 30.2 1.0 31.0 31.2 -0.7
6+ mos pre-ESRD care 47.8% 50.3% -5.1 50.2% 53.1% -5.7 50.4% 53.2% -5.6
# of comorbidities 2.5 2.4 1.8 2.5 2.4 2.1 2.6 2.4 10.1
Hemoglobin 9.9 10.0 -0.4 9.9 10.0 -0.5 10.0 9.9 1.0
Serum Creatinine 6.6 6.5 0.4 6.7 6.5 0.6 6.5 6.5 0.2
No insurance 7.1% 6.9% 0.9 6.8% 7.5% -2.7 6.1% 7.4% -4.9
White 68.6% 65.9% 5.7 68.9% 63.9% 10.6 68.8% 64.1% 10.1
Black 25.3% 28.1% -6.2 25.1% 29.2% -9.4 26.7% 29.4% -6.1
Asian 3.8% 3.8% 0.4 4.1% 3.8% 1.7 2.6% 4.2% -8.4
Hispanic 13.8% 12.6% 3.7 13.4% 12.4% 3.1 9.9% 12.2% -7.0
Employed 11.4% 12.4% -3.1 12.3% 13.7% -4.2 11.6% 13.6% -6.3
Facility Covariates
For profit 84.3 84.3 0.1 81.1 81.1 0.0 83.3 83.4 -0.3
# of nurses 9.1 9.2 -2.0 10.0 10.2 -3.8 9.2 10.7 -26.5
# of technicians 9.8 9.9 -0.5 9.7 9.8 1.2 9.0 9.7 -10.6
# of social workers 1.1 1.3 -13.9 1.1 1.4 -16.8 1.1 1.3 -10.4
# of HD stations 24.0 24.0 -0.5 24.2 24.4 -1.2 23.5 24.6 -10.9
Median income $50,874 $51,343 -2.32 $50,618 $50,496 0.6 $50,470 $51,368 -4.5
Bachelors degree + 23.4 25.0 -10.8 24.0 25.1 -8.2 23.5 25.7 -15.4
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